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In order to protect the body from a wide range of harmful environmental agents, the 
intestine has developed a number of barrier mechanisms to limit the entry of potential 
hazards. These include the physical barrier formed by the epithelial layer and the 
intestinal immune system that is important to induce either tolerance against food antigens 
and intestinal flora or inflammatory responses against dangerous microorganisms.  
It has been demonstrated that tolerance against commensal bacteria is strictly 
compartmentalized, in the sense that the systemic immune system is completely 
unprimed by these bacteria. It was demonstrated that the mLNs function as a “firewall” 
confining induction of tolerance to the mucosa while the systemic immune system remains 
ignorant to these bacteria.  
However, in these studies how the bacterial flora is excluded from the entrance in the 
bloodstream via the intestinal blood vessels has not been analyzed.  
Here, we describe a new barrier that we called the GVB (gut vascular barrier) that plays a 
fundamental role in controlling the spreading of molecules and bacteria to systemic sites. 
We found that intestinal endothelial cells (ECs) express the main components of TJs 
(occludin, JAM-A, Cldn-12, ZO-1 and cingulin) and AJs (VE-cadherin and junctional β-
catenin), indicating the presence of a barrier that excludes bacteria from passing through 
the paracellular route. In addition, we observed the existence of a “gut vascular unit” 
(GVU) whereby ECs were associated with enteric glial cells and pericytes, whose role in 
the establishment of the endothelial barrier phenotype remains to be analyzed. 
Moreover, we show that GVB integrity could be modified by Salmonella typhimurium 
infection. Indeed, upon infection ECs up-regulated the expression of Plvap, that has been 
previously used as a marker of immature/damaged vascular barrier in the brain, and up-
regulated caveolin-1, the major component of caveolae. These changes correlated with a 
higher permeability of the endothelium to small molecules and to bacteria.  
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One way by which S. typhimurium could modify the barrier properties of the intestinal 
blood vessels could be through the negative regulation of the Wnt/β-catenin signaling 
pathway. Indeed, we found that the activation of β-catenin was reduced upon Salmonella 
infection in vitro. Consistently, we found that Salmonella was incapable to modify ECs 
permeability and to spread systemically in mice where β-catenin was constitutively 
activated by genetic means only in vascular ECs. Furthermore, it appeared that the TTSS 
encoded by Salmonella pathogenicity island-2 was involved in the regulation of Wnt/β-
catenin signaling pathway in ECs. 
Finally, preliminary results show that the microbiota could induce GVB maturation and 
maintenance. However, the mechanisms involved in these processes as well as the 
bacterial species responsible for this process have not been investigated yet. 	   	  





In order to protect itself from a wide range of harmful environmental agents, the body has 
developed a number of barrier mechanisms to limit the entry of potential hazards. 
The organ mostly challenged by foreign material is the intestine. It has to constantly deal 
with innocuous food antigens and with an enormous number of commensal microbes that 
reaches 1014 bacteria in the human intestine, with close to 1000 distinct species, without 
considering archea, fungi, and viruses (Eberl, 2010). In the lower intestine, these 
organisms have evolved together with the host establishing a mutualistic relationship. 
Indeed, the microbes benefit from a constant nutrient supply while the host benefits from 
microbial degradation of plant polysaccharides and other dietary substances, of 
xenobiotics and they provide a barrier against potential pathogens (Hooper et al., 2012). 
Therefore, the union between the host and his microflora can be seen as a new functional 
entity termed a “superorganism” (Eberl, 2010). Despite the symbiotic relationship, the 
presence of the microbiota poses immense health challenges. For this reason, the 
intestine has adapted different strategies to limit opportunistic invasions by the resident 
microbiota and to maintain symbiotic host-microorganism relationship avoiding 
pathologies such as bacteremia and chronic inflammation (Hooper and Macpherson, 
2010). Two main methods are used for these purposes: the structural 
compartmentalization that minimizes bacterial–epithelial cell contact and the presence of 
specialized immune cells responsible in handling intestinal bacteria and food antigens in a 
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1.1 Physical Barrier 	  
1.1.1 The epithelial barrier 
 
The intestinal epithelium is a permeable barrier essential in preventing the uncontrolled 
passage into the host connective tissue of food or bacteria, and is involved in regulating 
the fluid absorption and secretion. Intercellular tight junctions (TJ) and adherens junctions 
(AJ), located near the apical surface of the intestinal epithelial cells, prevent paracellular 
traffic, whereas the brush border on the apical side avoids microbial attachment and 
invasion (Brown et al., 2013). Apart from the columnar absorptive epithelium, several 
specialized cells are involved in the creation and maintenance of the intestinal 
homeostasis. One of them is the M cell, located in the epithelium lining the secondary 
lymphoid organs such as Peyer’s patches (PP), colonic patches and isolated lymphoid 
follicles. These cells are characterized by irregular microvilli on the apical membrane, 
consistent with their function to transport antigens, and a by pocket-like microfold structure 
on the basal side that contains T and B lymphocytes, macrophages and dendritic cells 
(DC) (Goto and Kiyono, 2012). Additional support for the maintenance of the barrier 
function is given by other specialized epithelial cells such as goblet cells, important for the 
formation of the mucus layer, and Paneth cells, that secrete antimicrobial peptides (Fig. 
1.1), both of which will be described in detail in the next sections. 
In the last decade, it has become evident that the epithelial layer is not merely a physical 
barrier but it takes part in immunological processes discriminating between harmless and 
potentially harmful stimuli. Indeed, epithelial cells express a wide range of pattern 
recognition receptors (PRR), including Toll-like receptors (TLR) as well as nucleotide-
binding oligomerization domain (NOD)-like receptors (NLRs) that recognize bacterial 
microbe-associated molecular patterns (MAMP) shared by pathogens and the gut 
microbiota. The key mechanism to discriminate invasive pathogens, which can cross the 
epithelial monolayer, from the commensal microbiota, and to prevent responses to the 
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abundant bacterial components in the gut lumen preserving the ability to mount responses 
against pathogens is the compartmentalization of PRRs to the basolateral membrane or 
into the cytosol (Artis, 2008; Iliev et al., 2007; Rakoff-Nahoum et al., 2004). For example, 
TLR5, which recognizes bacterial flagellin, is expressed exclusively on the basolateral 
membrane allowing intestinal epithelial cells to induce an inflammatory response only 
against invading bacteria (Gewirtz et al., 2001).  
Additionally, commensal bacteria can actively modulate inflammatory responses 
modulating NF-κB signaling pathway in the epithelial cells. Indeed, it has been shown that 
apical TLR9 stimulation by commensal bacteria induces the ubiquitination of IκB that 
accumulates in the cytoplasm preventing NF-κB activation, whereas basolateral TLR9 
signals results in the activation of NF-κB transcriptional activity (Lee et al., 2006). Non-
pathogenic bacteria can reduce NF-κB activation also by inducing the expression of 
peroxisome proliferator-activated receptor gamma (PPAR-γ), which favors the export of 
RelA NF-κB subunit out of the nucleus reducing its transcriptional activity (Kelly et al., 
2004). 
Intestinal epithelial cells contribute to maintenance of the intestinal hypo-responsiveness 
to harmless stimuli also interacting with the underlying antigen presenting cells and 
conditioning them through the secretion of cytokines (Iliev et al., 2007). Such conditioning 
renders DCs “tolerogenic”, i.e. unable to induce inflammatory responses and capable to 
induce tolerogenic T cell responses (Iliev et al., 2009a; Iliev et al., 2009b) (Rimoldi et al., 
2005). In contrast, in presence of inflammatory signals, the intestinal epithelium releases 
inflammatory cytokines and chemokines that recruit non-educated DCs, competent in 
inducing inflammatory responses (Iliev et al., 2007).  
Numbers of factors, known to be produced by epithelial cells, are involved in the DC 
conditioning. Among those, transforming growth factor-β (TGF-β), retinoic acid (RA), 
prostaglandin (PG) E2 and thymic stromal lympopoietin (TSLP) have been shown to play 
a major role in the induction of tolerance (Iliev et al., 2007). 
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Figure 1.1: Physical and immunologic barriers for intestinal microbiota containment (Hooper, 2009). 
Goblet cells secrete mucins that assemble into a mucus layer. Bacteria are abundant in the outer mucus layer, 
whereas the inner layer remains sterile. Together with the mucus layer, antimicrobial proteins further help to 
avoid direct contact between bacteria and epithelial cells. LP-DCs can actively sample bacteria from the lumen 
extending their dendrites between the epithelial cells. Migrating into the Peyer's patches and mesenteric lymph 
nodes, DCs loaded with bacteria induce B cells to differentiate into IgA+ plasma cells. Recirculating plasma 
cells produce IgA that are then transcytosed across the epithelium where they limit  bacterial penetration into 
the host tissues. 
 
 
1.1.2 Mucus Layer 
 
The first layer of defense between the gut and the external environment is the mucus 
layer. Specialized epithelial cells, namely goblet cells, secrete mucin glycoproteins that 
form a thick gel-like mucus layer that in the colon has been estimated to be around 50 μm 
in mice and 100μm in rat  (Johansson et al., 2011). It is composed of two different layers: 
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the outer lose and easily removable mucus and the inner epithelium-adherent layer. 
Staining the intestine with 16S ribosomal RNA probes has revealed that unlike the inner 
mucus layer that is completely sterile, commensals colonize the outer layer (Johansson et 
al., 2008) that avoids their wash out and allows their growth providing glycans as nutrient 
source. Studies on mucus composition have established that it contains carbohydrates, 
immunoglobulins, cellular proteins, as well as lipids and electrolytes but the major 
component of both layers is mucin (Muc)2. Muc2 is a large glycoprotein characterized by 
a protein core heavily O-glycosylated with numerous carbohydrate chains that are 
important for Muc2 function (Johansson et al., 2008). Different studies in Muc2 deficient 
mice that lack mucus layer have demonstrated that Muc2 mucin plays an important role in 
the maintenance of intestinal physiology. Indeed, it has been shown that Muc2−/− mice 
develop spontaneous colitis by 7 weeks of age (Van der Sluis et al., 2006) as well as 
colon cancer after 6–12 months (Velcich et al., 2002). Furthermore Muc2−/− mice are 
more susceptible to infection by enteric pathogens such as Salmonella typhimurium 
(Zarepour et al., 2013) or Citrobacter rodentium (Bergstrom et al., 2010). This is due to 
the fact that the lack of Muc2 and therefore deficiency of both mucus layers facilitates 
direct contact between pathogens and epithelium as well as the contact with commensal 
microbes, that in this way are able to translocate across the epithelium and into the lamina 
propria (Bergstrom et al., 2010). 
Recently, Shan et al. have demonstrated that the mucus acts not only as a physical 
barrier between gut tissue and intestinal bacteria but it also influences the function of 
antigen presenting cells, in particular DCs, and epithelial cells contributing in establishing 
tolerance toward food and microbiota-derived antigens. Indeed, on one side, DCs 
conditioned with glycosylated Muc2 show reduced expression of pro-inflammatory 
cytokines such as interleukin (IL)-12 counteracted by an increased production of anti-
inflammatory cytokines (IL-10) when stimulated with lipopolysaccharide (LPS). This 
results in the generation of regulatory T (Treg) cells. On the other side, upon Muc2 
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stimulation intestinal epithelial cells produce molecules that support DC regulatory 
function, such as TGF-β, TSLP and IL10 (Shan et al., 2013). 
 
1.1.3 Antimicrobial peptides 
 
The second way by which the bacteria-epithelial cell contact is limited is the secretion of 
antimicrobial peptides that are particularly important in the small intestine since it lacks a 
continuous mucus layer (Brown et al., 2013). Several antimicrobial peptides have been 
identified such as defensins and C-type lectins that are able to kill bacteria via enzymatic 
digestion of bacterial cell wall or inner membrane, and lipocalins that are able to inhibit 
bacterial growth by interfering with the acquisition of essential metals like iron (Brown et 
al., 2013). The expression of these proteins is regulated by different mechanisms. Indeed 
some defensins, for example some α-defensins that are produced by neutrophils and 
Paneth cells located at the base of the small intestinal crypts, are expressed constitutively 
without any bacterial stimulation (Putsep et al., 2000). However, other antimicrobial 
peptides are produced upon the ligation of PRRs, such as TLRs or NOD receptors. For 
example, it has been shown that some C-type lectins, such as regenerating islet-derived 
protein (REG)-3β and REG-3γ are expressed in the small intestine upon TLR engagement 
and myeloid differentiation primary response 88 (MyD88) signaling pathway activation 
(Vaishnava et al., 2008) similarly to some α-defensins that are expressed upon NOD2 
recognition of bacterial muramyl dipeptide (Kobayashi et al., 2005).  
The functional importance of antimicrobial proteins was demonstrated using gain-of-
function and loss-of-function animal models. Indeed, it has been demonstrated that mice 
lacking Paneth cells have an increased penetration of commensal bacteria and pathogens 
such as Salmonella. Indeed without antimicrobial peptides, S. typhimurium is able to 
overcome the epithelial barrier and spread systemically (Vaishnava et al., 2008). The 
resistance to this pathogen could be restored in transgenic mouse models by inducing the 
production of the human defensin-5 in the mouse gut (Salzman et al., 2003). 
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The importance of antimicrobial peptides for the maintenance of the intestinal 
homeostasis has been supported also by studies on human pathologies. Indeed, reduced 
levels of α-defensins were detected in samples from Crohn’s disease patients (Wehkamp 
et al., 2005) suggesting a role for enteric α-defensins in the pathogenesis of inflammatory 
bowel diseases.  
 
 
1.2 Immune Barrier 	  
1.2.1 IgA 
 
A further line of defense to uncontrolled bacterial translocation through the host epithelial 
cell layer involves the secretion of immunoglobulin (Ig)A.  
IgAs specific for the intestinal microflora are produced upon stimulation of B cells by DCs 
that have sampled luminal bacteria in the PPs (Macpherson and Uhr, 2004) or directly 
from the gut lumen (Rescigno et al., 2001). Together with DCs, also epithelial cells can 
directly induce class switch recombination from IgM to IgA by producing B cell activating 
factor belonging to the TNF family (BAFF) and the proliferation-inducing ligand (APRIL) 
upon TLR stimulation. BAFF and APRIL recognized by their receptor on B cells induces 
the activation of NFκB pathway that up-regulates the expression of the activation-induced 
cytidine deaminase (AID), the enzyme required for the class switch recombination 
(Macpherson et al., 2012). 
Induced IgAs in the intestinal lymphoid follicles undergo recirculation from the mucosa 
through the lymph into the thoracic duct to home back via the blood stream in the intestine 
as IgA-producing plasma cells. The homing back to the site of induction is possible 
because retinoic acid (RA) produced by intestinal DCs up-regulates the α4β7 integrin and 
the CCR9 and CCR10 chemokine receptors on B cells that bind respectively to the 
chemokines CCL25 and CCL28 expressed in the intestinal mucosa (Mora et al., 2006). 
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Once in the intestine the IgA dimers are transported through the epithelium in the 
intestinal lumen via the polymeric Ig receptor present at the basolateral membrane of the 
epithelial cells. The “secretory” IgAs are then released in the lumen by the proteolysis of 
the extracellular domain of the polymeric Ig receptor (Macpherson et al., 2012). 
The induction of secretory IgA in the gut is specifically induced by the microflora since 
germ-free mice have reduced numbers of mucosal IgA-producing cells (Slack et al., 2012) 
but it is independent on the presence of germinal centers and T cells. Indeed, Tumor 
necrosis factor (TNF) receptor–I deficient mice that have rudimentary PPs and no B cell 
follicles and T cells deficient mice (T cell receptor (TCR) β-/- δ-/-) show similar levels of 
IgA-producing plasma cells specific for the microbiota compared to normal C57Bl/6 mice 
(Macpherson et al., 2000). This indicates that a large portion of mucosal IgAs are 
produced in a “primitive” fashion, independently from T-cell-mediated immunity. However 
some reports have demonstrated also a T-cell dependent component of IgA induction in 
which Foxp3+ regulatory T cells are involved (Cong et al., 2009). 
Different mechanisms of action of IgA have been suggested. Peterson et al. have found 
that germ-free immunodeficient Rag1-/- mice administered with Bacteroides 
thetaiotaomicron show a more robust innate immune response compared to wild-type 
(WT) mice and to Rag1−/− mice implanted with B. thetaiotaomicron specific IgA-producing 
hybridoma cells (Peterson et al., 2007). This finding indicates that IgA can act reducing 
intestinal pro-inflammatory signaling. Moreover, IgA may also have a role in controlling the 
composition of the microbiota. Indeed, mice lacking AID enzyme show an overgrowth of 
predominantly of the segmented filamentous bacteria (SFB) (Suzuki et al., 2004), which 
have been associated to an increase of Th17 inflammatory responses (Ivanov et al., 
2009) (Gaboriau-Routhiau et al., 2009). Beyond “buffering” the mucosal responses, IgAs 
could act directly on commensal colonization of the intestine by influencing bacterial 
growth rate or survival (Slack et al., 2012). 
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1.2.2 Mucosal Dendritic cells 
 
The intestinal immune system, generally referred to as GALT (gut-associated lymphoid 
tissue) is usually divided into effector sites, which consist of lymphocytes scattered 
throughout the intestinal epithelium and lamina propria (LP), and organized tissues, like 
PPs, mesenteric lymph nodes (mLNs) and the smaller isolated lymphoid follicles (ILFs), 
responsible for the induction of immune responses (Fig. 1.2). PPs and ILFs are located in 
the small intestine, whereas isolated clusters of lymphoid cells similar to ILFs are found in 




Figure 1.2: Schematic representation of GALT. Organized lymphoid structures - Peyer's patches and 




Different cell types compose the intestinal immune barrier in the intestine, but between 
them an essential role in maintaining the immune homeostasis is played by DCs.  
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In the PPs different populations of DCs were identified. On the basis of their cell-surface 
receptor expression they were classified into CD11chiCD11b+CD8α- (myeloid) DCs 
localized in the sub-epithelial dome, CD11chiCD11b-CD8α+ (lymphoid) DCs present in the 
interfollicular regions and CD11chiCD11b-CD8α- DCs located at both sites (Iwasaki and 
Kelsall, 2001). Important functional distinctions also exist between these subpopulations. 
Indeed the CD11b+ subset is endowed with the ability to induce IL-10-producing T cells 
and prime Th2 cells. On the other hand, CD8α+ and CD11b− CD8α− PP DCs drive the 
differentiation of Th1 cells (Iwasaki and Kelsall, 2001). DCs from PPs can also be 
described in terms of their expression of the chemokine receptors CX3CR1 and CCR6. 
CX3CR1+ DCs are associated with the follicle-associated epithelium (FAE) during the 
steady state, whereas CCR6+ DCs are recruited from the dome region to the FAE during 
infection (Salazar-Gonzalez et al., 2006). 
A large number of mononuclear cells, including macrophages and DCs, reside also in the 
intestinal LP. In the last decade, there was a growing interest on the different 
subpopulations of these mononuclear phagocytes and on their role in regulating mucosal 
innate and adaptive immune responses in both the steady-state and inflammatory 
settings. 
Within the small intestine lamina propria, two developmentally and functionally non-
overlapping populations of mononuclear phagocytes have been classified depending on 
the expression of CX3CR1 (the fractalkine receptor) and CD103 (αE integrin) (Fig. 
1.3)(Schulz et al., 2009; Varol et al., 2009). 
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Figure 1.3: Mononuclear phagocytes in the small intestinal lamina propria (Varol et al., 2010). Classical 
DC precursors give rise to CD103+ lamina propria DCs that can be subdivided into a CD11b− and a CD11b+ 
population. Upon antigen stimulation, CD11b+CD103+ DCs migrate in a CCR7-dependent manner to the mLN. 
Ly6C+ monocytes differentiate locally into CX3CR1+ mononuclear phagocytes endowed with the capacity to 
penetrate epithelium by extending trans-epithelial dendrites and sample luminal antigens. CX3CR1+ LP 
mononuclear phagocytes are not able to migrate to lymph nodes. 	  
 
 
CD103+ LP cells represent bona fide DCs. They develop from non-monocytic precursor 
cells (Varol et al., 2009) and they expand in response to fms-like tyrosine kinase 3 ligand 
(Flt3L) and granulocyte macrophage colony stimulating factor (GM-CSF) (Bogunovic et 
al., 2009; Schulz et al., 2009). They were found to express CCR7, allowing them to 
migrate to the mLN (Bogunovic et al., 2009; Jaensson et al., 2008; Schulz et al., 2009) 
where they induce, at steady state, the differentiation of naive CD4+ T cells into FoxP3+ 
regulatory T cells, through a mechanism dependent on RA and TGF-β (Coombes et al., 
2007; Sun et al., 2007). Furthermore they induce the expression of the gut-homing 
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molecules CCR9 and α4β7 on responding T cells (Johansson-Lindbom et al., 2005). 
Under inflammatory conditions the tolerogenic features of the CD103+ DCs are lost. 
Indeed, in a model of T-cell induced colitis, CD103+ DCs sorted from mLNs have reduced 
ability to induce FoxP3+ regulatory T cells but they polarize T cells toward a Th1 
phenotype (Laffont et al., 2010). 
CX3CR1+ cells are now defined as macrophages, which derive from Ly6Chigh blood 
monocytes (Varol et al., 2009) and are dependent on macrophage colony stimulating 
factor (M-CSF) for their development (Schulz et al., 2009). This population has been 
identified as the one capable to sample the intestinal lumen extending protrusion through 
the epithelial cells (Niess et al., 2005) without disrupting the epithelial integrity (Rescigno 
et al., 2001). Moreover, TLR ligands and microbes such as Salmonella have been shown 
to increase the luminal sampling of CX3CR1+ cells (Chieppa et al., 2006), which has been 
demonstrated to be dependent on MyD88 signaling pathway (Arques et al., 2009). 
Recently, it has been found that LP CX3CR1+ cells can acquire antigens also from the 
blood stream that are then cross-presented to CD8+ T cells which then express IL-10, IL-
13 and IL-9 and could migrate into the intraepithelial compartment (Chang et al., 2013). 
Although they are loaded efficiently with luminal antigens, it has been shown that 
CX3CR1+ cells cannot migrate from LP to mLNs indeed they do not up-regulate CCR7 
even in presence of LPS (Schulz et al., 2009). Moreover, they poorly prime naive T cells, 
but preferentially support Th1/Th17 cell differentiation (Niess and Adler, 2010), which is 
favoured by commensal-derived factors, such as ATP (Atarashi et al., 2008). However, 
CX3CR1 has been shown to be import to oral tolerance establishment. For instance, 
CX3CR1-deficient mice showed impaired local Treg cell expansion and abrogated 
establishment of oral tolerance due to a reduced production of IL-10 by CX3CR1-
expressing macrophages (Hadis et al., 2011).  
In inflammatory conditions such as during a DSS-induced colitis model, DC-depleted mice 
reconstituted with Ly6Chigh monocyte with a resulting imbalance of the CD11b+ CX3CR1+ 
versus the CD11b− CD103high LP subsets, show severe signs of colitis indicating that 
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Ly6Chi monocyte-derived CD11b+ CX3CR1+ have a pro-inflammatory phenotype (Varol et 
al., 2009). 
Recent studies on intestinal dendritic cells and macrophages have added further insight 
on the populations present in the LP and their functions. Indeed, Cerovic et al. have found 
that not all the CX3CR1+ cells can be classified as macrophages. Indeed, a migratory 
population of CD103- CX3CR1int has been found in the lymph which has characteristics 
comparable to the ones of the “classical” CD103+ DC subset as they respond to Flt3 and 
present efficiently the antigen to CD4 and CD8 T cells, although they induce Th1 and 
Th17 cell polarization (Cerovic et al., 2013). Diehl at al. have investigated the possibility 
that also the CX3CR1high population is able to migrate into the mLNs in a CCR7-dependent 
manner upon antibiotic-induced dysbiosis (Diehl et al., 2013).  
On the other hand, using 2-photon microscopy, CD103+ cells have been found localized in 
the intestinal epithelium and they were found able to extend dendrites toward the lumen to 
take up bacteria but not soluble antigens (Farache et al., 2013). 
 
 
1.3 Oral tolerance vs Systemic ignorance 	  
The intestine is exposed continuously to a vast amount of foreign antigens that it has to 
discriminate. Indeed, it must distinguish between pathogens and harmless antigens, such 
as food proteins and commensal bacteria. For the first ones strong immune responses are 
required. By contrast, active immunity against harmless antigens would be detrimental, for 
instance hypersensitivity responses against dietary antigens or the microbiota can lead to 
inflammatory disorders such as coeliac disease and Crohn’s disease, respectively 
(Mowat, 2003). Therefore, the usual response to gut antigens is the induction of what is 
called oral tolerance. However, an important difference exists between the oral tolerance 
to gut bacteria and to food antigens: whereas the tolerance to food proteins affects both 
local and systemic immune responses, tolerance to gut microbes is only local while the 
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systemic immune system is left ignorant to these bacteria (Macpherson et al., 2000; 
Macpherson and Smith, 2006; Pabst and Mowat, 2012). Therefore in the next paragraphs, 
I will use the term oral tolerance to indicate the tolerance to food antigens and systemic 
ignorance referring to the (local) tolerance to the microbiota. 
 
1.3.1 Antigen uptake 	  
Physical barriers, described in the previous paragraphs, prevent the access of harmful 
bacteria into the underlying tissue. However, in the gut there are different ways in which 
antigens can reach and be taken up by LP antigen presenting cells (Fig. 1.4). One entry 
port for antigens is formed by M cells, which are present within the epithelium overlaying 
the Peyer's patches and lymphoid follicles. These cells actively transport molecules from 
the lumen into the underlying dome region (Pabst and Mowat, 2012). It is not yet clear 
whether the M-cell mediated antigen uptake is important for oral tolerance induction. 
Indeed, some reports shows that the lack of PP, by administration of lymphotoxin-β 
receptor antibody during gestation, reduced oral tolerance (Fujihashi et al., 2001), while 
others demonstrate that normal oral tolerance can be inducted in the absence of PPs 
(Spahn et al., 2001; Spahn et al., 2002). Moreover, M cells have been identified also in the 
intestinal villous epithelium, which are, similarly to PPs-M cells, capable to transport 
antigens and to induce antigen-specific immune responses in a PP-independent manner 
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Figure 1.4: Mechanisms of antigen uptake in the gut (Pabst and Mowat, 2012). (I) Transcellular transport 
of particulate antigens via M cells; (II) Paracellular passage of soluble antigens; (III) Transcellular transport of 
antigens across epithelial cells; (IV) Exosome-dependent transport of antigens via MHC-II+ enterocytes; (V) 
CX3CR1high macrophages sample luminal antigens extending dendrites across the epithelial layer. The 
antigens that reach the LP are taken up by the migratory CD103+ DCs. 
 
 
Other routes by which antigens can reach LP have also been described. For instance, it 
has been reported that antigens can be transported by neonatal Fc receptor for IgG from 
the gut lumen into the intestinal lamina propria (Kelsall and Rescigno, 2004). Antigens 
with low molecular weight can diffuse into the LP though the tight junctions between 
epithelial cells while high molecular weight molecules can be transported through the 
epithelium by transcytosis. Luminal material can be transported into the intestinal tissue 
also within exosomes derived from major histocompatibility complex class II (MHC-II) 
expressing epithelial cells (Pabst and Mowat, 2012). Furthermore, it has been 
demonstrated that CX3CR1-expressing mononuclear phagocytes can directly sample 
antigens from the lumen extending dendrites crossing tight junctions between epithelial 
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cells without compromising the integrity of the epithelial barrier (Rescigno et al., 2001) 
(Niess et al., 2005). This process of antigen uptake has been shown to be mediated by 
MyD88-dependent signaling evoked by the interaction of epithelial TLRs with microbial 
products (Chieppa et al., 2006). Recently, it has been demonstrated that also the CD103+ 
DCs, patrolling the epithelial layer, can extend dendrites toward the lumen and sample 
particulate antigens (Farache et al., 2013). Additionally, at steady state goblet cells deliver 
soluble antigens with low molecular weight from the intestinal lumen to underlying CD103+ 
cells (McDole et al., 2012). 
 
1.3.2 Oral tolerance establishment 
 
It is known from many years that animals fed with a protein have reduced subsequent 
response to a systemic challenge with the same antigen (Macpherson and Smith, 2006). 
These classical experiments of delayed type hypersensitivity (DTH) responses are used to 
evaluate the establishment of oral tolerance to food proteins.  
Although the principal characteristic of oral tolerance is the systemic T cell 
hyporesponsiveness, it is well known that the main site of oral tolerance induction is the 
mLN. Indeed, it has been shown that mice lacking mLNs but not the one lacking PPs, 
cannot induce systemic tolerance to food antigens (Spahn et al., 2002; Worbs et al., 
2006). However, different observations suggested that oral tolerance could be induced 
outside the GALT. For instance, the intraperitoneal injection of serum from tolerized mice 
induces tolerance in the recipient animal (Macpherson and Smith, 2006). Furthermore, 
antigen delivery via the portal vein induces a response similarly to oral delivered antigens 
(Goubier et al., 2008). The induction of oral tolerance is possible outside the GALT 
because orally administered antigens can disseminate systemically and reach the liver via 
the portal circulation (Li et al., 2004; Pabst and Mowat, 2012).  
Different specialized antigen presenting cells are involved in oral tolerance induction such 
as liver sinusoidal endothelial cells, Kupffer cells and plasmacytoid DCs favor oral 
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tolerance induction (Thomson and Knolle, 2010). The importance of liver as “extra-
intestinal” place where oral tolerance is established is demonstrated also by the finding 
that portacaval shunting prevents the establishment of oral tolerance (Callery et al., 1989). 
 
1.3.3 Systemic immune ignorance 
 
Contrary to food proteins, intestinal microbiota is highly immunogenic indeed very low 
numbers of these bacteria given intravenously induce strong immune responses 
(Macpherson et al., 2000), indicating that in the case of commensal bacteria tolerance is 
established locally in the GALT while the systemic immune system remains ignorant. This 
setup is of primary importance because it avoids the tolerization of the systemic immune 
system, which is then able to respond efficiently to systemic sepsis from a commensal or 
a related bacterium (Macpherson and Smith, 2006).  
This compartmentalization is preserved by mLNs that work as a system of containment, or 
“firewall” (Hooper and Macpherson, 2010). Indeed, bacteria that have penetrated epithelial 
barrier or that have been sampled by intestinal DCs to induce mucosal immunity are 
carried to the mLNs where they remain confined since bacteria loaded-DCs cannot reach 
the thoracic duct and, hence, the systemic circulation (Fig. 1.5) (Macpherson and Smith, 
2006). The fundamental role of mLNs as firewall is demonstrated by the fact that after oral 
administration of Enterobacter cloacae (an aerobic component of the microbiota of SPF 
mice in some colonies), bacteria were recovered only from mLNs and not from spleen and 
liver that remain sterile (Macpherson and Uhr, 2004). Moreover, C57/BL6 mice in specific 
pathogen-free (SPF) conditions showed no serum IgG or IgA specific for E. cloacae but 
only specific secretory IgA in the intestinal washings (Macpherson et al., 2000). By 
contrast, removing mLNs before infecting mice via oral gavage resulted also in spleen 
colonization (Macpherson and Uhr, 2004) demonstrating that adaptive systemic ignorance 
is lost. 
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Figure 1.5: Anatomy of immune responses to antigens of intestinal origin (Macpherson and Smith, 
2006). Food proteins can induce both local and systemic tolerance, reaching the mLNs via the lymph or the 
liver via the hepatic portal vein. On the contrary, commensal bacteria carried by DCs to the mLNs induce only 
local immune tolerance while the systemic immune system remains unprimed. This is possible since the mLNs 
act as “firewall” that block further penetration of bacteria in the thoracic duct. 
 
 
Voedisch et al. have also demonstrated that mLNs block the access to systemic tissue to 
Salmonella functioning as a barrier preventing lethal systemic infection (Voedisch et al., 
2009).  
Together with the fundamental role of mLNs in preventing bacteria systemic 
dissemination, we envisage also the presence of a barrier at the endothelial cell level that 
blocks the penetration of bacteria into the blood stream via the blood capillaries located 
just beneath the epithelium (see Results section). 
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1.4 Blood Brain Barrier  
 
In 1904 Paul Ehrlich discovered that dyes injected into the vascular system were taken up 
by all organs except the brain and the spinal cord (Engelhardt, 2003). However, the term 
"blood brain barrier" (BBB) was coined later by Lewandowsky that demonstrated that 
neurotoxic agents were effective only when directly injected into the brain but not when 
injected into the vascular system (Engelhardt, 2003). Thanks to the use of electron-
microscopy, we have now deeper knowledge on which cell types form the BBB and how 
they modulate its development and maintenance.  
 
1.4.1 Structure and function of BBB 
 
The BBB is a selective barrier critical for the protection of CNS from toxins and from 
fluctuations in blood composition and, on the other hand, it is fundamental for the delivery 
of nutrients to the brain (Liebner et al., 2011). 
The BBB is formed by endothelial cells (ECs) that, with their structural properties, tightly 
restrict the trafficking of ions, molecules and cells between the blood and the brain. These 
properties include: specialized TJs and AJs between adjacent ECs that limit the 
paracellular movement of ions and molecules; the expression of transporters required for 
the movement of nutrients, like water-soluble amino acids and glucose, into the brain and 
for transporting out potentially toxic substances; lower rates of transcytosis compared to 
peripheral endothelium and the lack of fenestrations. Moreover, ECs limit extravasation of 
immune cells from the blood into the brain reducing the expression of leukocyte adhesion 




Figure 1.6: Schematic representation of the BBB (Siegenthaler et al., 2013). (a) Cellular components of 
the BBB. Capillaries (purple) in the CNS are covered by a pericyte (green), which are embedded in the 
vascular extracellular matrix (orange). Astrocytes (blue), extending cellular processes, contact the blood 
vessels. Together these cells form the Neuro-Vascular unit. (b) Barrier components of the brain ECs. TJs and 
AJs create a tight paracellular barrier and polarize the cells creating distinct luminal and abluminal membrane 
compartments, each of which is characterized by the expression of different transporters. The ECs are also 
characterized by low rates of transcytosis, mediated by low levels of Plvap protein. In addition ECs express 
low levels of leukocyte adhesion molecules, including ICAM1. 
 
 
The junctional complexes between endothelial cells include AJs and TJs, which are both 
important for the maintenance of cell-cell adhesion and for the activation of signaling 
pathways that control many EC functions (Paolinelli et al., 2011).  
In AJs, which are important for initiating cell-to-cell contacts, transmembrane cadherin 
proteins, in particular the endothelial specific Vascular Endothelial (VE)-cadherin, span the 
intercellular cleft and are linked through the cytoplasmic domain to the scaffolding proteins 
p120-catenin and β-catenin or plakoglobin, which, in turn, through the binding to α-
catenin, promote the anchorage to the actin cytoskeleton (Dejana, 1996; Giannotta et al., 
2013). Although the extracellular domain of VE-cadherin is necessary for clustering, the 
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intracellular association to the actin cytoskeleton is necessary to provide strength and 
cohesion to the junction (Navarro et al., 1995). Studies carried out using ECs with a null 
mutation of VE-cadherin (Vittet et al., 1997) or using an anti-VE-cadherin blocking 
monoclonal antibody (Corada et al., 1999) have highlighted the importance of VE-cadherin 
for the maintenance of the vascular integrity.  
TJs are particularly abundant and complex in the BBB where there is the need to strictly 
control paracellular permeability to polar solutes. They are formed by transmembrane 
proteins such as occludin (Furuse et al., 1993), claudins (Furuse et al., 1998), and 
junctional adhesion molecules (JAM) (Martin-Padura et al., 1998) linked to a number of 
cytoplasmic scaffolding and regulatory proteins such as Zonula occludens (ZO)-1, ZO-2, 
ZO-3 and cingulin (Abbott et al., 2010). These junctions in the brain capillaries significantly 
block the paracellular transport also of small ions such as Na+ and Cl-, so that the 
transendothelial electrical resistance (TEER), which is typically 2–20 ohm x cm2 in 
peripheral capillaries, can be more than 1,000 ohm x cm2 in brain endothelium (Abbott et 
al., 2006). 
Occludin was the first integral membrane protein to be found associated to TJ (Furuse et 
al., 1993). This protein was shown to be dispensable for TJ formation since occludin-
deficient mice are viable and develop normal TJs in most tissues (Saitou et al., 2000). By 
contrast, proteins belonging to claudin protein family were found to be necessary for the 
formation of TJ strands (Morita et al., 1999). The claudin gene family includes more than 
20 isoforms with high homology with occludin and are differently expressed among 
different tissues (Engelhardt, 2003). Peculiar of the brain endothelium are claudin (Cldn)-
5, Cldn-12 (Nitta et al., 2003) and Cldn-3 (Liebner et al., 2008) that are believed to be 
responsible for the establishment of endothelial barrier function. Indeed, it has been 
demonstrated that in experimental allergic encephalomyelitis and in glioblastoma 
multiforme the selective loss of Cldn-3, together with the loss of Cldn-1 and Cldn-5, is 
associated with a loss of BBB integrity (Wolburg et al., 2003) (Liebner et al., 2000). 
Moreover, it has been shown that the increased Cldn-3 expression by Wnt/β-catenin 
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pathway activation in ECs is associated to an enhanced barrier formation (Liebner et al., 
2008). Furthermore, claudin-5 deficient mice have a severely compromised and leaky 
BBB and die shortly after birth (Nitta et al., 2003). Therefore it appears that disappearance 
of either Cldn-3 or Cldn-5 from the tight junctional complexes can result in a compromised 
BBB.  
Together with occludin and claudins also JAM-A, B and C are expressed by brain 
endothelial cells and are involved in the formation and the maintenance of the tight 
junctions and of BBB integrity (Wyss et al., 2012; Yeung et al., 2008). 
The effectiveness of the TJs is regulated via the intracellular scaffold proteins ZO-1, ZO-2 
and ZO-3 which link the junctional molecules claudin and occludin via cingulin to the 
cytoskeleton and to several cytoplasmic signaling molecules that are involved in 
controlling the assembly and disassembly of TJ (Abbott et al., 2006). For instance, it has 
been shown that ZO-1 is a substrate of protein kinase C, which is crucial for the formation 
and regulation of TJs (Stuart and Nigam, 1995). 
In brain capillaries TJs, together with AJs, beyond the “gate” function, are also required for 
the maintenance of cell polarity, i.e. a correct differential distribution of enzymes and 
carriers between luminal and abluminal compartments (Paolinelli et al., 2011). The brain 
endothelial transporters that supply the brain with nutrients include the Glut-1 glucose 
carrier, Lat-1 amino acid carrier and transporters for nucleosides. Other transporters 
include the luminal P-glycoprotein (P-gp) and multidrug resistance-related proteins (MRP) 
that require ATP or the Na+ gradient created by the abluminal Na+,K+-ATPase to move 
compounds against a concentration gradient (Abbott et al., 2006).  
However, brain ECs in culture do not have all these features characteristic of the BBB-
phenotype indicating that these properties are induced by interactions with other cell 
types, namely pericytes, astrocytes and microglia, that together are termed as 




1.4.2 Barriergenesis induction and regulation 
 
Stewart and Wiley with transplantation experiments have demonstrated for the first time 
that vessels derived from the coelomic cavity of chick embryos transplanted in the 
embryonic quail brain acquired BBB characteristic while brain vessels implanted in 
mesodermal tissue lack barrier characteristics (Stewart and Wiley, 1981). These 
observations are the direct evidence that the ECs are not “committed” to have barrier 
characteristics but these are induced by the neural tissue during embryogenesis. 
The earliest BBB marker to be expressed is the glucose transporter Glut-1 (at rodent 
embryonic day 12) (Daneman et al., 2010). It is initially expressed on both luminal and 
abluminal sides of the ECs while later in development, due to an increased demand for 
glucose, it has a higher localization at the abluminal membrane (Engelhardt, 2003). 
Although some TJ proteins such as cldn-5, occludin and ZO-1 are also present in blood 
vessels at the same embryonic stage (Daneman et al., 2010) the barrier functionality at 
this stage is incomplete since BBB becomes impermeable to horseradish peroxidase only 
at E13 in chick and at E15 in rats (Siegenthaler et al., 2013). At these early stages of 
development the BBB leakage could be attributed to the fact that brain blood vessels have 
still leaky properties such as high levels of trancytosis – identified by the expression of 
plasmalemma vesicle associated protein (Plvap) – and the expression of LAMs, in 
particular of ICAM-1 that promote leukocyte infiltration (Daneman et al., 2010). During the 
late gestation and the postnatal stages (in rodents) there is a gradual maturation of the 
BBB with an increased density and complexity of TJs (Kniesel et al., 1996) and the loss of 
the expression of ICAM-1 and Plvap (Daneman et al., 2010). 
The cell types that together form the NVU have been shown to play an important role 
during all these phases of the BBB development.  
One of the main players are the pericytes, a cell population that has been found at high 
density in the brain and closely associated to the nascent vessels at the early stages of 
development (Daneman et al., 2010). In vitro BBB model obtained co-culturing mouse 
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brain ECs with primary rat brain pericytes have suggested that pericytes are able to 
regulate BBB properties (Dohgu et al., 2005). Recently it has been demonstrated that 
brain pericytes are required for the stabilization of newly formed vessels and for 
development and maintenance of the BBB. Indeed, mice that lack the platelet derived 
growth factor B (PDGFBB) signaling that is required for pericytes recruitment in the brain 
show ECs hyperplasia, increased vessel diameter and permeability (Daneman et al., 
2010). Moreover, the lack of pericytes coverage during brain development have been 
associated to an increased expression of “leaky” vascular barrier, such as Plvap and 
LAMs while “tight” barrier features, i.e. TJ proteins and transporters, remained unchanged 
(Armulik et al., 2010; Daneman et al., 2010). These in vivo studies also suggested that 
pericytes are necessary for the establishment of astrocytes-vessel contact, which are 
important for the maintenance of BBB properties during the postnatal period (Armulik et 
al., 2010).  
Indeed, in the postnatal period (that corresponds to the second half of gestation in 
humans) astrocytes contact the brain endothelium via cellular processes or end-feet and 
start to influence the endothelial barrier properties (Daneman et al., 2010). One features of 
the astrocytes is the polarity of the cellular membrane at the end-feet structure. Indeed, 
some proteins, such as the water channel Aquaporin-4 (Aqp4), are expressed at the 
abluminal surface of the astrocyte processes. However the connection between the 
expression of Aqp4 and the maintenance of the BBB is not yet known (Liebner et al., 
2011).  
In vitro studies, using astrocyte-conditioned medium or the direct contact between 
astrocytes and ECs (Dehouck et al., 1990; Rubin et al., 1991), together with in vivo 
experiments in which astrocytes were transplanted into non-neural tissue (Janzer and 
Raff, 1987) have demonstrated their role in barrier maturation. 
Recent studies have described different ways by which astrocytes are able to promote 
BBB integrity. One of these is the activation of the Hedgehog (Hh) pathway. Indeed 
Alvarez et al. have demonstrated that both human and mouse astrocytes secrete Sonic 
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Hh (Shh) and that brain ECs express high levels of the receptor Patched-1 and of the 
downstream protein Smoothened suggesting that this pathway is used by these two 
cellular populations to communicate (Alvarez et al., 2011). The inactivation of Hh pathway 
in ECs leads to a decrease in the expression of TJ proteins, to higher vascular 
permeability and to increased leukocyte extravasation, all markers of BBB disruption 
(Alvarez et al., 2011).  
Additionally, the binding of the astrocyte-derived retinoic acid to its receptor RARβ on 
human ECs has been implicated in inducing barrier properties. Indeed, RA increases the 
expression of VE-cadherin, ZO-1 together with Glut-1 and P-gp transporters (Mizee et al., 
2013). 
Although all this evidence shows the important role of astrocytes and pericytes in 
enhancing BBB development, embryonic neural progenitors have been suggested to play 
an important role in inducing BBB properties in the initial phase of development. Indeed, 
even in the absence of pericytes, in an embryonic phase in which astrocytes are not yet 
generated, brain ECs express different BBB-associated proteins (Daneman et al., 2010). 
The central role for canonical Wnt ligands as neural progenitor signal for BBB 
development has emerged from different animal models that target the Wnt ligands or 
directly the β-catenin (Daneman et al., 2009; Liebner et al., 2008; Stenman et al., 2008).  
Wnt ligands are a family of 19 secreted glycoproteins able bind to Frizzled (Fzd) and low-
density lipoprotein receptor-related protein (LRP) receptors. In the canonical Wnt 
signaling, receptor ligation leads to the inactivation of a destruction complex composed by 
glycogen syntase kinase-3β (GSK-3β), the scaffolding protein axin and adenomatosis 
polyposis coli (APC) avoiding the phosphorylation of β -catenin and therefore its 
proteosome-mediated degradation. If β-catenin is not phosphorylated, it translocates to 
the nucleus where it regulates the transcription of target genes by binding to T-cell factor/ 
lymphoid enhancing factor (Tcf/LEF) transcription factors (Paolinelli et al., 2011). 
Moreover, Wnt/β-catenin signaling pathway activation can be regulated also by secreted 
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antagonists, such as Dickkopf homologs (Dkk1–4) and secreted frizzled-related protein 
families (sFRPs, 1–5) (MacDonald et al., 2009) (Fig. 1.7). 
 
Figure 1.7. Scheme of Canonical Wnt/β-catenin signaling pathway (Liebner and Plate, 2010). When no 
Wnt ligands are present or are inhibited by WIF, sFRPs and Dkk. cytosolic β-catenin is targeted to proteolytic 
degradation through phosphorylation by the APC-Axin-GSK3β destruction complex. In the "on-state" 
stimulation of Fzd receptors and their co-receptors Lrp5/6 by Wnt ligands, leads the accumulation of β-catenin 
in the cytoplasm, which is then able to enter into the nucleus activating target gene transcription through 
association with Tcf/LEF transcription factors. 
 
 
Using β-catenin-activated expression of nuclear β-galactosidase reporter mice, it was 
demonstrated that Wnt/ β -catenin signaling pathway is activated in the vessels 
penetrating into the embryonic brain till E17.5 when its activation decreases (Liebner et 
al., 2008). The Wnt signaling follows the same kinetics of brain angiogenesis and BBB 
development supporting the idea that Wnt ligands are involved in brain vascularization 
	  
 36 
and induction of the BBB properties. Indeed, Liebner, et al. have found that the Wnt/β-
catenin pathway activation by Wnt3a induces the up-regulation of Cldn-3 and 
correspondingly a decrease of the Plvap “leaky” protein (Liebner et al., 2008). Moreover, 
other studies have demonstrated that also Wnt7a-mediated activation of Wnt/β-catenin 
pathway induces the up-regulation of BBB markers including Glut-1 and other transporters 
such as slc7a1 and slc7a5 (Daneman et al., 2009; Stenman et al., 2008).  
The Wnt signaling pathway is responsible not only for barrier maturation during 
embryogenesis but also for the BBB maintenance in the adult. Indeed, the inactivation of 
the pathway in postnatal mouse brain ECs leads to the down-regulation of the cldn3 and 
the up-regulation of Plvap (Liebner et al., 2008).  
ECs lose their barrier properties also under pathological conditions such as ischemia, 
brain tumors or Alzheimer’s disease. In these conditions BBB microvessels up-regulate 
Plvap (Carson-Walter et al., 2005; Sparks et al., 2000) that is therefore associated to 
immature or disrupted BBB.  
Plvap protein has been localized to caveolae and trans-endothelial channels of 
fenestrated capillaries (Herrnberger et al., 2012b; Stan et al., 2012). Studies using Plvap-
deficient mice have demonstrated the importance of Plvap also in the regulation of the 
permeability of fenestrated endothelial (not the brain since it has a continuous ECs layer). 
Indeed, mixed background Plvap -/- mice show loss of plasma proteins, tissue edema and 
dyslipidemia that finally results in multiple organ disfunction (Herrnberger et al., 2012b; 
Stan et al., 2012). 
 
 
1.5 Salmonella typhimurium infection 
 
Salmonella enterica serovars are Gram-negative facultative intracellular bacteria that 
through food and water can cause local gastroenteritis or systemic disease called typhoid 
fever, depending on the serovar. Indeed, in humans infections by Salmonella enterica 
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serovar Typhi (hereafter referred to as S. typhi) causes typhoid fever while Salmonella 
enterica serovar Typhimurium (referred to as S. typhimurium) induces only locally 
restricted infection. By contrast, mice are susceptible to oral infection with S. typhimurium, 
but not S.typhi, resembling the human systemic disease (Voedisch et al., 2009). Therefore 
S. typhimurium oral infection in mice is widely used as model of human systemic infection. 
The resistance of mice to S.typhi was firstly associated to an inhibitory effect of the host 
intestinal microbiota on the growth of the inoculated Salmonella. However, germfree mice 
were equally resistant to S.typhi systemic infection indicating that the microbiota does not 
influence the ability of different Salmonella serovars to spread systemically (Collins and 
Carter, 1978). Interestingly, Collins at al. have also demonstrated that the ability of S.typhi 
to reach distal organs such as spleen and lung is not obtained even in the absence of 
phagocytic cells that are necessary for bacterial clearance (Collins and Carter, 1978) 
indicating that other mechanisms are involved in the discrimination between local and 
systemic disease caused by different Salmonella strains. 
 
1.5.1 Mechanisms of invasion 
 
The preferential site of entry for S. typhimurium are the M cells present in the PPs (Jones 
et al., 1994; Pascopella et al., 1995). M cells continuously sample the gut lumen and 
transport particulate antigens including live bacteria into the LP where they are taken up 
by immune cells (Pabst and Mowat, 2012). One way by which Salmonella is transported in 
the PPs is through the caveolae (Lim et al., 2010).  
Caveolae are formed by lipid rafts rich in sphingolipids and cholesterol that oligomerize in 
the presence of caveolin-1 and caveolin-2 to form 60-80 nm diameter pits (Parton and 
Simons, 2007). They have been implicated in endocytosis and transcytosis, cholesterol 
trafficking, signaling and they can be used as entry portals by different pathogens such as 
E coli (Sukumaran et al., 2002) and Salmonella (Hoeke et al., 2013; Lim et al., 2010). In 
particular, it has been shown that Salmonella can down-regulate caveolin-2 expression by 
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increasing the expression of miR-29a both in vivo and in vitro (Hoeke et al., 2013). 
Experiments using epithelial cell lines have suggested that the reduced expression of 
caveolin-2 causes defects in epithelial cell renewal, which can favour pathogen invasion 
through the damaged epithelium (Hoeke et al., 2013). By contrast, Lim et al. have shown 
that Salmonella induces the up-regulation of caveolin-1 in PPs isolated from old mice 
favouring its trancytosis (Lim et al., 2010). 
Together with this passive transport, Salmonella is also able to induce rearrangements of 
the M cells cytoskeleton resulting in loss of integrity of the PP epithelium that allows rapid 
spreading to the organs before an immune response can be initiated (Jones et al., 1994; 
Pascopella et al., 1995). Moreover, it has been shown that Salmonella could transverse 
the gut epithelium, a process dependent on type III secretion system (TTSS)-1 for 
epithelial cell invasion and on TTSS-2 for trafficking to the basolateral side (Muller et al., 
2012).  
In addition to the passage through the M cells, Salmonella can invade the intestinal LP via 
an active sampling mechanism mediated by mononuclear phagocytes expressing 
CX3CR1 that have been described in the section ‘Mucosal dendritic cells’. 
Salmonella, like other intracellular bacterial pathogens have the ability to multiply inside 
vacuoles in the infected host cells. These vacuoles first acquire markers of the early 
endosomes, such as the early endosomal antigen 1 (EEA1), which are then replaced by 
markers of the late-endosomal system including Rab7, the lysosomal glycoproteins 
LAMP-1, LAMP-2 and LAMP-3/LIMP-1 and the vacuolar ATPase responsible for 
phagosome acidification. However these vacuoles never acquire the mannose-6-
phosphate receptor (M6PR), which delivers lysosomal hydrolases to the endosomal 
system. Therefore S. typhimurium actively manipulates host cell factors to create an 
intracellular compartment, distinct from a classical phagosome permissive for bacterial 
growth (Bakowski et al., 2008).  
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Two distinct TTSS encoded on Salmonella pathogenicity islands (SPIs) 1 and 2 are 
involved in invasion and survival in the host cells (Fig. 1.8).  
 
Figure 1.8. SPI-1 and SPI-2 TTSS in Salmonella infection. (modified from (Gilbreath et al., 2011)) After 
adhesion to the epithelium through fimbrial and nonfimbrial adhesins, Salmonella spp are translocated across 
the epithelial cell using SPI-1 T3SS effectors. SPI-2 effectors are then required for intracellular survival and for 
the maturation of the early endosome vesicles to the specialized vacuole, termed as Salmonella-containing 
vacuole (SCV). The SCV localizes near the Golgi apparatus that serves as an intracellular replicative niche. 
 
 
TTSSs are needle-like protein complexes that translocate bacterial virulence proteins 
(effectors) from the bacterial cytoplasm directly into the host-cell cytoplasm. These 
translocated effectors are able to alter host-cell functions such as signal transduction, 
cytoskeletal architecture, membrane trafficking, and cytokine gene expression (Galan, 
2001). 
Genes of the SPI-1 TTSS are activated upon contact with epithelial cells and are required 
for translocating effectors across the host cell plasma membrane (Galan, 2001). Some of 
these effector proteins, such as SopB, SopE, SopE2 and SipA are able to disrupt the 
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epithelial cell barrier by altering the localization of TJ proteins such as ZO-1 and occludin 
(Boyle et al., 2006). Such disruption may lead also to the exposure of TLR localized on the 
basal membrane of the epithelial cells to bacterial ligands inducing indirectly the activation 
of inflammatory response (Galan, 2001).  
TTSS-1 mutant strains administered by the oral route show an attenuated phenotype, 
demonstrating that SPI-1 encoded genes are necessary for the efficient entry of 
Salmonella into the host tissue (Galan and Curtiss, 1989). However TTSS-1 deficient 
strains are still able to reach the intestinal LP by a mechanism that is independent from 
the Salmonella intrinsic capability to invade the intestinal epithelium. The way by which 
also TTSS-1 mutant Salmonella penetrate into the intestine is through DCs, indeed 
depletion of DCs during the early phases of infection strongly reduces the bacterial 
spreading (Hapfelmeier et al., 2008). In line with this finding, it was shown that TTSS-1 is 
necessary for the colonization of PP, liver and spleen but not of mLNs, which indicates 
that the colonization of mLNs is mediated, by DCs sampling and migration to the draining 
lymph node (Martinoli et al., 2007; Voedisch et al., 2009). 
SPI-1 TTSS effector proteins have also been implicated in the stimulation of 
polymorphonuclear leukocytes (PMN) recruitment (SipA protein) (Lee et al., 2000) and in 
the induction of fluid accumulation and diarrhea (SopB, SopD, and SopA) (Wood et al., 
2000). However, TTSS-1 secreted protein SipB has been shown to be responsible for the 
induction of apoptosis in macrophages via caspase-1 activation (Hersh et al., 1999). 
The SPI-2 encoded TTSS has been associated to the ability of Salmonella to survive in 
host cells and to spread systemically (Ochman et al., 1996). Indeed, S. typhimurium 
mutated strains in TTSS-2 genes cannot establish systemic infection upon intra-peritoneal 
injection (Shea et al., 1996). In vitro studies have shown that expression of SPI-2 is 
induced inside the macrophages in the acidic phagosomal environment, which induces 
the activation of SPI-2-encoded regulatory system SsrA/B (Cirillo et al., 1998; Deiwick et 
al., 1999). Interestingly, Cirillo et al. have found that in contrast to SPI-1 deficient strains 
that are not able to colonize PPs but are still able to reach mLNs, SPI-2 mutants invade 
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PPs but are not found in the mLNs, liver and spleen indicating that SPI-2 is required to 
avoid Salmonella clearance by macrophages (Cirillo et al., 1998). Recently, it has been 
demonstrated by 2-photon microscopy that TTSS-2 is also involved in the invasion of the 
epithelium. Indeed, mutants for TTSS-2 reach the LP through the epithelial layer less 
efficiently compared to the WT strain (Muller et al., 2012). 	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AIM OF THE STUDY 
 
 
The intestine is continuously challenged by a vast amount of foreign antigens including a 
large community of commensal bacteria, collectively called the microbiota. Although the 
microbiota has established a symbiotic relationship with the host, it poses immense health 
challenges. For this reason, the intestine has adapted different strategies to limit 
opportunistic invasions by the resident microbiota avoiding pathologies such as 
bacteremia and chronic inflammation. In the past years, a lot of effort was made at 
understanding how the mucosal tolerance and the systemic ignorance is maintained, 
focusing in particular on the role of the epithelial cells and of the intestinal immune 
system. 
In this thesis, we investigated whether the intestinal endothelial cells, beyond the physical 
barrier and the intestinal immune system, form another layer of protection avoiding 
indiscriminate trafficking of molecules and bacteria from the gut into the blood stream.  
So we proceeded through these steps using as model the blood-brain barrier whose 
features have been extensively studied: 
• Identification of the “intestinal vascular unit” (counterpart of the neurovascular unit 
found in the brain) and analysis of the intestinal endothelial cell phenotype, 
focusing on the composition of the TJs and AJs; 
• Identification of markers to define the intestinal endothelial barrier integrity, starting 
from the analysis of the expression of Plvap, Cldn-3 and caveolin-1 since the up-
regulation of Plvap and caveolin-1 together with the down-regulation of Cldn-3 was 
associated to damaged BBB. To induce endothelial damage, we infected mice with 
Salmonella typhimurium; 
• Functional studies of the gut vascular barrier in which vascular permeability to 
molecules with different molecular mass was measured; 
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• Study of the mechanisms behind intestinal endothelial barrier modifications. We 
focused on Wnt/β-catenin signaling pathway since in the brain the activation of this 
signaling pathway leads to enhanced endothelial barrier properties. Moreover, we 
investigated if and how Salmonella could interfere with Wnt/β-catenin signaling 
pathway activation in endothelial cells to favour its systemic spreading. 
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8-10 weeks old WT C57BL/6J mice were purchased from Harlan Laboratories.  
For some experiments, β-cateninlox(ex3)/lox(ex3) mice (Harada et al., 1999) (from E. Dejana, 
FIRC Institute of Molecular Oncology, Italy) were used. In these mice the exon3 of the β-
catenin gene (Catnb) that contains the serine/threonine residues phosphorylated by the 
GSK3β kinase, was flanked by two LoxP sequences. These mice were crossed with 
Cdh5(PAC)-CreERT2 mice (Monvoisin et al., 2006) (from E. Dejana), where upon 
tamoxifen treatment the Cre recombinase is expressed in VE-cadherin positive endothelial 
cells. To induce recombination Cdh5(PAC)-CreERT2/β-cateninlox(ex3)/lox(ex3) mice were fed 
with tamoxifen-enriched food (TAM 400, Harlan) for two weeks. Upon treatment, the β-
catenin exon3 is excised resulting in a gain-of-function (GOF) for the β-catenin in an 
endothelial specific manner. 
Cdh5(PAC)-CreERT2 /β-cateninlox(ex3)/lox(ex3) mice were screened for the presence of Cre 
enzyme by PCR using primers CreA 5'-CCA AAA TTT GCC TGC ATT ACC GGT CGA 
TGC-3' and CreB 5'-ATC CAG GTT ACG GAT ATA GT-3'. The cycling protocol used is 
the following: 
 
Table. 3.1: Cdh5(PAC)-CreERT2 /β-cateninlox(ex3)/lox(ex3) genotyping cycling protocol. 
 
 
To ensure that the exon 3 was efficiently excised in the endothelial cells of the intestine, 
small pieces of intestinal tissue were lysed, genomic DNA was extracted and tested for 
Step Temp. (°C) Time (s)
1 95 300
2 95 60




the presence of the exon 3-deleted β-catenin allele. The PCR amplification protocol is the 
following: 
 
Table. 3.2: Cycling protocol used to analyze cre-mediated recombination in mouse intestinal tissues. 
 
 
Primers pair used to verify the cre-mediated recombination is: Del-Fw 5’-GCT GCG TGGG 
ACA ATG GCT AC-3’ and Del-Rv 5’-TGA GCC CTA GTC ATT GCA TAC-3’.	   If the cre 
recombinase is present, the exon 3 is excised from the β-catenin gene in endothelial cells, 
and therefore two amplification bands are expected after genomic PCR: the lower one 
which is the deletion band and the upper one that corresponds to the wild-type allele 
present in non-ECs present in the preparation (Fig. 3.1).	  
	  
Figure 3.1: Cre mediated deletion of β-catenin exon 3 in vivo. Genomic PCR of duodenum, jejunum, ileum 
and colon from Cdh5(PAC)-CreERT2/β-cateninlox(ex3)/lox(ex3) mice. The lower band corresponds to the deleted 
allele and its weaker intensity is due to the high amount of non-ECs present in the lysate in which the 
recombination event does not occur. 
 
 
For in vitro experiments, MyD88 KO mice, and TLR4 KO mice, obtained by Dr S Akira 




















Step Temp. (°C) Time (s)
1 95 300
2 95 60




Mice were bred and maintained at IFOM-IEO Campus animal facility under specific 
pathogen-free conditions. All experiments were performed in accordance with the 





S. typhimurium strains on SL1344 background were used for in vivo and in vitro 
experiments. For the in vivo experiments, an aroA mutant of Salmonella, auxotrophic for 
aromatic amino acids was used. It is characterized by an attenuated ability to replicate in 
vivo. For the in vitro experiments the strains used were: WT invasive strain (FB62); a S. 
typhimurium strain defective for the survival into the phagosome (BA83, SPI-2 KO); a 
noninvasive strain (BA34, SPI-1 KO) or into an endotoxin mutant (FB61, msbB). Moreover 
in some experiments WT DH5α E. coli strain or a modified strain expressing invasin from 
Yersinia enterocolitica was used. Bacterial strains were grown at 37°C in Luria broth 
supplemented with the appropriate antibiotics. 
 
3.3 Lung endothelial cells isolation 
 
For each isolation, three to four mice were used. Mouse lungs were removed from the 
thoracic cavity and placed in Hank's Balanced Salt Solution (HBSS) 1X. Lungs were cut 
into small pieces and then incubated with collagenase A (1,5 mg/mL; Roche Diagnostic) 
and DNase I (8 U/mL; Roche Diagnostic) for 75 min at 37°C under agitation. After the 
incubation, cell suspension was filtered through a 70-μm cell strainer and then through a 
40-μm filter and cell suspension was centrifuged for 5 min at 1200 rpm. The red blood 
cells were lysed with a hypotonic lysis buffer, washed and the cell pellet was subjected to 
the CD45 positive selection using CD45 Microbeads kit (Miltenyi Biotec). CD31 positive 
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cells were then purified from the CD45 negative population using the CD31 MACS beads 
(Miltenyi Biotec). After selection, the CD45-CD31+ cells were washed with complete 
MCDB131 medium (GIBCO), then resuspended in complete MCDB131 containing 100 
μg/mL heparin (Sigma-Aldrich) and 50 μg/mL EC growth supplement (homemade from 
calf brain) and plated into a gelatin-coated T-75 tissue culture flask.  
 
3.4 In vitro infection 
 
7*105 lung ECs were seeded in 6 well plates coated with gelatin. When they reached 
confluence (after 2 days), cells were infected with a ratio cell:bacteria 1:10 for 90 min. 
Cells were then washed and medium was replaced with complete MCDB131 containing 
100 μg/mL gentamycin. After 150 min ECs were lysed for the subsequent RNA analysis. 
 
3.5 Mice infection 
 
C57BL/6J, β-cateninlox(ex3)/lox(ex3) or Cdh5(PAC)-CreERT2 /β-cateninlox(ex3)/lox(ex3) mice were 
infected with 109 S.typhimurium ΔaroA via oral gavage and after 2h, 6h, 24h and 48h 
blood was collected from heart and serum was tested for the presence of alanine 
aminotransferases (ALT, Sentinel Diagnostic) following manufacturer protocol. PPs, 
mLNs, spleen and liver were harvested and incubated 1h at 37°C with gentamycin to kill 
external bacteria. Organs were then digested with 1mg/ml collagenase D (Roche) for 30 
minutes at 37°C and cells were plated on terrific broth agar plates together with sodium 







Duodenum, jejunum and ileum of untreated or infected mice were fixed o/n in 
paraformaldehyde (PFA), L-Lysine pH 7.4 and NaIO4 (periodate-lysine-paraformaldehyde 
(PLP) fixative buffer). Then they were washed, dehydrated with 20% sucrose for at least 4 
hours and included in OCT. 10 μm cryosections were rehydrated, blocked with 0.1M Tris-
HCl pH 7.4, 2% fetal bovine serum (FBS), 0.3% Triton X-100 before staining them with 
Plvap, Cldn-3, Cldn-5, Cldn-12, ZO-1, JAM-A, Occludin, VE-cadherin, GFAP, CD31, 
CD34, cingulin antibodies. Primary antibodies were incubated o/n at 4°C. Slices were then 
incubated with the appropriate fluorofore-conjugated secondary antibody. Before imaging, 
nuclei were counterstained with 4',6-diamidin-2-fenilindolo (DAPI). Confocal microscopy 
was performed on a Leica TCS SP5 laser confocal scanner mounted on a Leica DMI 
6000B inverted microscope equipped with motorized stage. Violet (405nm laser diode), 
blue (488nm argon laser), yellow (561nm laser diode) and red (633nm laser diode) laser 
lines that have been used for excitation. All images were acquired with a HCX PL APO 
40X (NA 1.25) oil immersion objective. Software used for all acquisitions was Leica LAS 
AF and ImageJ or Imaris (Bitplane) for images analysis. 
 
3.7 Permeability assay 
 
C57/BL6, β-cateninlox(ex3)/lox(ex3) and VE-Cadherin-CreERT2/β-cateninlox(ex3)/lox(ex3) mice were 
orally infected with 109 S.typhimurium ΔaroA. Immediately after infection or after 1h, 4h or 
24h were anesthetized with 2, 2, 2-Tribromoethanol and intestinal loops were exteriorized 
and ligated in different parts of the small intestine. 2mg of FITC-Dextran 20 KDa (Sigma-
Aldrich) were injected in the loop. After 1h blood samples were taken from the heart and 




3.8 RNA isolation and quantitation of gene expression by real-time PCR 
 
Total RNA was purified from cells using RNeasy Kits (QIAGEN). cDNA synthesis was 
performed using SuperScript III reverse transcriptase (Invitrogen) and random hexamers. 
Real-time PCR reactions were carried out using the SYBR Green PCR kit on the Applied 
Biosystems 7500 Fast Real-Time PCR System. Expression levels for each sample were 
normalized to the expression levels of Rpl32. Results were quantified using the 2-ΔΔCt 
method. 
 
Table. 3.3: Primer Table 
 
 
3.9 2-Photon intravital microscopy 
 
Before starting the intravital experiments mice were starved o/n to limit the presence of 
feces into the intestine, which could interfere with the acquisition of the images. Mice were 
left untreated or infected for 4 hours with 109 S.typhimurium ΔaroA before anesthetizing 
them with 3-4% inhaled isoflurane. Animals were kept under anesthesia for all the 
experiment, for maximum 2h and then sacrificed. For surgery, a 1-cm long incision was 
made on the skin to expose the peritoneal wall. An additional small incision was made on 
the peritoneum to expose the abdominal cavity. A 3- to 4-cm loop from the ileum was 
externalized and the mucosal surface was exposed by making a 1-cm cut longitudinally 
through the gut wall (Fig. 3.2). To avoid the loss of blood from broken capillaries, a 
cauterizer was used to cut the intestine. The intestinal content was removed washing with 
PBS, without disrupting the mucosal layer, and the outer layer of the intestine was fixed to 





a glass slide with surgical glue. The opened intestine was covered with a glass coverslip 
and the space between the two glass slides was filled with PBS. Once the surgery is 
completed, the animal was placed on a heating surface set at 37°C and 2mg 4KDa or 
0.5mg 70KDa-FITC Dextran (Sigma-Aldrich) were injected into the tail vein. Intravital 
imaging was performed on a Leica TCS SP5 laser confocal scanner mounted on a Leica 
DM 6000CFS upright microscope, equipped with a Chameleon-XR (Coherent) Ti:Sapphire 
laser source directly coupled to the scanning head of the microscope using an infrared 
port. A Leica HCX APO L20X (NA 1.0) water immersion objective was employed for the 
analysis. For time-lapse image acquisition the stacks (with a z-step of 3 µm) over a depth 
of about 70 µm were acquired every 30 s and the two-photon excitation of FITC dye was 
performed at λ = 900 nm with a 512x512 pixel size and a pixel dwell time of 2.8 msec.  
 
Figure 3.2: Surgery scheme. An incision was made on the skin and then on the peritoneum to expose the 
abdominal cavity. A 3- to 4-cm loop from the distal ileum was exposed. A small cut was done using a 
cauterizer along the intestinal wall to expose the mucosal layer. 
 
 
3.10 Analysis of intravital imaging of vascular permeability  
 
For image analysis at select time-points, an area of interest (5×5 μm) was chosen inside 
and outside, considering as outside the region immediately adjacent to the blood vessel. 
The fluorescence intensity was determined in the areas of interest for both the FITC-
dextrans. For each time-point, the fluorescence intensity was measured for 10 areas 
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inside and 10 areas outside the blood vessels. To quantify the permeability of the 
intestinal blood vessels, the ratio between the outside and the inside fluorescence 
intensity and percent fluorescence was calculated by normalizing on the fluorescence ratio 
at the start of the acquisition. 
 
3.11 Antibiotic treatment protocol 
 
Animals were administered with ampicillin (1 g/L), vancomycin (500 mg/L), neomycin 
sulfate (1 g/L), and metronidazole (1 g/L; all antibiotics from MP Biomedicals) ad libitum in 
drinking water for four weeks (Rakoff-Nahoum et al., 2004) before infecting them with 109 
S.typhimurium ΔaroA. Since it is known that mice generally refrain from drinking the 
antibiotic cocktail for the bad taste of metronidazole, we frequently check the mice to be 
sure of their welfare. Moreover the depletion of intestinal microbiota was confirmed plating 




Statistical differences were evaluated using GraphPad Prism software. Values were 
compared using either a student t-test for single variable, 2-way ANOVA for two variables 
or non-parametric 2-tailed Mann-Whitney tests depending on the distribution of the data. 
In all the cases, the statistical test used is indicated in each figure legend. 






4.1 “Gut Vascular Unit” identification and characterization 
 
4.1.1 Cellular composition of GVU and intestinal endothelial cell phenotype 
characterization 
 
The blood brain barrier is a specialized structure formed by the brain microvascular 
endothelium that strictly controls the exchanges between blood and brain parenchyma 
protecting the central nervous system from the constantly changing milieu of the blood 
stream (Paolinelli et al., 2011). Also in the intestine there is the necessity to confine the 
foreign potentially dangerous material present in the gut lumen outside from blood stream 
to avoid systemic dissemination. It has been demonstrated that commensal bacteria that 
reach the lymphatics do not penetrate into the thoracic duct and therefore they do not 
reach the systemic circulation since they remain confined into the mLNs (Hooper and 
Macpherson, 2010; Macpherson et al., 2012). However, what are the mechanisms by 
which bacteria are excluded from systemic dissemination through the blood vessels are 
still unknown. 
We hypothesized that also in the intestine there was a control of the endothelial 
permeability and we wondered whether there was a structure similar to the one described 
for the BBB. We used the knowledge on the BBB characteristics as model to characterize 
the intestinal vascular barrier and the intestinal endothelial cells phenotype. 
In the BBB, ECs display peculiar features such as the lack of fenestration, low pinocytic 
activity, the presence of elaborated junctional complexes that includes TJ and AJ proteins 
and the polarized expression of selective transporters (Daneman and Rescigno, 2009; 
Paolinelli et al., 2011). The brain ECs were found associated with pericytes, embedded by 
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the basal lamina, neurons, microglia and astrocytes endfeet that altogether constitute the 
neurovascular unit (NVU), essential for CNS homeostasis (Cardoso et al., 2010). 
In accordance with previous studies that have demonstrated that there is an extensive 
network of glial cells within the LP, with processes that reach the epithelial cell layer (Bush 
et al., 1998; Neunlist et al., 2007; Neunlist et al., 2008) and blood capillaries (Hanani and 
Reichenbach, 1994), we found that in the mouse gut, enteric glial cells, identified with the 
expression of the intermediate filament GFAP, are abundant in the intestinal LP and they 
extend their projections to the villi tips (Fig. 4.1). Moreover, similar to astrocytes in the 
brain, GFAP-positive glia forms several endfeet-like structures surrounding blood vessels 
particularly when they are located underneath the epithelial basal membrane (Fig. 4.1). 
Furthermore, ECs are associated with pericytes, stained with α-smooth muscle actin (α-
SMA; Fig. 4.1). 
 
Figure 4.1: Intestinal Vascular Unit characterization. Confocal images showing blood vessels (red, 
CD31/PECAM-1), enteric glial cells (green, GFAP) in the upper panel or pericytes (green, α-SMA) in the lower 
panel in cryosections from intestines of C57/BL6 mice. Actin filaments were stained with phalloidin (blue). 









One peculiar feature of BBB capillaries is the presence of elaborated junctional complexes 
that includes TJ and AJ proteins. As shown in Figure 4.2A-F, similar to the cerebral 
endothelium, intestinal ECs express the main components of TJs, such as occludin (Fig. 
4.2A), the transmembrane junctional adhesion molecule–A (JAM-A, Fig 4.2C), claudin-5 
(Fig. 4.2E) and low levels of claudin-12 (Fig. 4.2F), as well as the cytoplasmic accessory 
proteins ZO-1 (Fig. 4.2B) and cingulin (Fig. 4.2D) involved in the connection of integral 
TJs to the actin cytoskeleton. Moreover, as shown in Figure 4.2B-C-D-F, also the 


























Figure 4.2: Intestinal endothelial cells express TJ proteins. Confocal images showing the localization of 
TJ proteins in blood vessels (CD31/PECAM-1, red). In green (A) Occludin, (B) ZO-1, (C) JAM-A, (D) cingulin, 
(E) claudin-5, (F) claudin-12. Every intestinal section was stained also with phalloidin (blue). Scale bars: (A, D) 
10 µm, (B, C, E, F) 20 µm.  
 
 
As shown in Figure 4.2E, claudin-5 seems to be expressed by a subset of CD31 positive 
vessels. To assess whether claudin-5 is differentially expressed by blood vessels and 
lymphatics, we stained the former with CD34 and the latter with LYVE-1 antibodies and 
Cldn-5 localization was evaluated. In Figure 4.3 the immunostaining demonstrates that 
Cldn-5 is expressed by LYVE-1 lymphatic endothelium but not by CD34 blood vessels. 
 
Figure 4.3: Lymphatics but not blood vessels express claudin-5. Confocal images showing the 
localization of claudin-5. In the upper panels, intestinal sections were stained for Cldn-5 (green) and CD34 
(red) to mark blood vessels while in the lower panels, sections were labeled with Cldn-5 (green) and LYVE-1 
(red) which is specifically expressed by lymphatic vessels. Every intestinal section was stained also with DAPI 








Essential for the formation of the TJs are the AJs since they hold ECs together. In the gut, 
endothelial cells express the transmembrane VE-cadherin (Fig. 4.4) that forms AJs by 
homophilic interaction. As shown in Figure 4.4, intestinal epithelial cells as well as 
endothelium express also β-catenin in the intercellular junctions. 
 
Figure 4.4: Adherens Junction proteins expression in intestinal endothelial cells. Confocal images 
showing the expression of AJ proteins on blood vessels (CD31/PECAM-1, red). In green VE-cadherin (upper 




Taken together these results demonstrate that in the intestine we can define a “gut 
vascular unit” (GVU) composed by pericytes, enteric glia that extends cellular processes 
around intestinal vessels and endothelial cells.  
Moreover, we found that intestinal endothelial cells express a peculiar set of TJs that 
probably allows these cells to restrict the trafficking of molecules within the paracellular 
space. However, the expression of transporters involved in the movement of substances 






adhesion molecules necessary for movement of immune cells from the blood into LP 
remain to be evaluated to have a complete picture of the intestinal endothelium properties.  
 
4.1.2 S. typhimurium modifies barrier properties of the intestinal endothelium 
 
In order to clearly define whether there is a vascular barrier in the intestine we analyzed 
the expression of Plasmalemma Vesicle Associated Protein-32 (Plvap/ MECA-32/ PV1) 
since in the brain it has been demonstrated that Plvap expression negatively correlates 
with the differentiation of the vasculature to form the BBB (Liebner et al., 2008). Indeed, 
when the endothelium differentiates to form the BBB at approximately E17, concomitantly 
to the activation of Wnt/β-catenin signaling pathway, MECA-32 antigen expression is 
downregulated (Hallmann et al., 1995) leading to increased barrier properties of the 
endothelium (Liebner et al., 2008). By contrast, BBB microvessels up-regulate Plvap 
under pathological conditions such as brain tumors or stroke (Carson-Walter et al., 2005). 
Analyzing Plvap expression in the small intestine by immunofluorescence, we found that 
at steady state all the 3 parts of the small intestine, namely duodenum, jejunum and ileum, 
do not express Plvap (Fig. 4.5). However, when mice were orally infected with Salmonella 
typhimurium, a pathogen capable to spread systemically in the mouse, we found that at 
early phases of infection Plvap was slightly up-regulated in CD34+ blood vessels of the 
jejunum and ileum and after 6h it was highly up-regulated in the same parts of the small 
intestine (Fig. 4.5). By contrast in the duodenum after infection Plvap is expressed at low 
levels only after 6h post-infection. Following the kinetics of Plvap expression, we found 
that at 24h after infection, the protein tends to return to basal levels in all the tracts of the 
intestine (Fig. 4.5). 
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Figure 4.5: Plvap expression on intestinal blood vessels. Confocal images showing blood vessels (green, 
CD34), Plvap (red) and cell nuclei (blue) in cryosections from different SI tracts of C57/BL6 mice at different 




4.1.3 Salmonella spreads systemically after oral infection 
 
To address whether the upregulation of Plvap correlates with reduced barrier properties of 
the intestinal endothelium and therefore with a systemic spreading of S. typhimurium, we 
challenged C57/BL6J mice intragastrically with 109 S. typhimurium ΔaroA. We used this 
auxotrophic mutant with low replicative capabilities in vivo because it allows us to evaluate 
the spreading of the bacteria reducing the effect of the bacterial replication on colony 
forming unit (CFU) counts. 








Figure 4.6: S. typhimurium spreading after oral administration. Mice were orogastrically inoculated with 
109 S.typhimurium ΔaroA bacteria. After 2h, 6h, 24h and 48h CFUs in PPs, mLNs, spleen and liver were 
determined. Each data point represents an individual mouse. Error bars represent SEM. Results are pooled 
from 3 independent experiments. Student unpaired t-test with Welch’s correction for unequal variances was 
used to evaluate statistical significance. *P<0.05. 
 
 
We found that during the early phases of infection the first organs to be involved are the 
PPs and later mLNs and liver and finally the spleen are colonized (Fig. 4.6). Moreover, 
between 6h and 24h when there is the highest number of CFU in the liver, also alanine 
transaminases (ALT), indicators of liver damage, are high in the serum (Fig. 4.7). 
 



































































Figure 4.7: Alanine transaminases after S. typhimurium infection. Blood from mice infected with 109 S. 
typhimurium ΔAroA was collected and serum was tested for the presence of alanine transaminases (ALT), as 
indicators of liver damage. Each circle represent the result obtained from one single mice. Error bars 
represent SEM. Data are representative of 3 independent experiments with similar results. 
 
 
4.1.4 S.typhimurium infection modulates caveolae formation in intestinal vessels 
 
Different studies have demonstrated that Plvap is necessary for the formation of 
endothelial diaphragms in the fenestrae and caveolae both in vitro (Ioannidou et al., 2006; 
Stan, 2004) and in vivo (Herrnberger et al., 2012a; Herrnberger et al., 2012b; Stan et al., 
2012) where the presence of diaphragms in organs with fenestrated vessels like the 
intestine are important in maintaining the endothelial barrier function. Indeed, Plvap 
deficient mice, that have impaired formation of diaphragms and consequently a leaky 
fenestrated endothelium, showed a selective loss of plasma proteins, edema, dyslipidemia 
and lethal protein-losing enteropathy (Stan et al., 2012). In the context of the blood-brain 
barrier, caveolin-1, the major component of the caveolae, has been associated to BBB 
breakdown, since in the early phase after barrier damage it is upregulated in the vessel of 
the lesion (Nag et al., 2007). Moreover it has been demonstrated that caveolae are 
involved in the entry of virus and bacteria such as E.coli K1 through brain microvascular 
endothelial cells (Sukumaran et al., 2002) and S. typhimurium, which has been 











demonstrated to be transported into the intestinal M cells through caveolin-1 expressing 
caveolae (Lim et al., 2010).  
Based on these published data, we wondered whether also in intestinal endothelial cells 
caveolin-1, the caveolae membrane scaffolding protein, is expressed and if its expression 
is modulated during infection along with Plvap. Therefore we analyzed by 
immunofluorescence the expression of caveolin-1 in the intestine of untreated mice and 
mice orally infected with 109 S. typhimurium bacteria after different time points. 
 
Figure 4.8: Caveolin-1 is expressed in lymphatic and blood endothelial cells in the intestine and it is 
up-regulated upon infection. Confocal images showing Plvap expression (stained in green), caveolin-1 
(CAV-1 in red) and nuclei were stained with DAPI (blue) in cryosections from different SI tracts of C57/BL6 
mice at different time points after oral gavage with 109 S.typhimurium ΔaroA. Bars: 10 µm. Images are 
representative of three independent experiments. 
 
 
















We found that caveolin-1 was expressed in all the three part of the small intestine in both 
blood vessels, that after infection could be identified by the expression of Plvap, and in 
lymphatic vessels, that can be recognized also based on their position in the center of the 
villi. As shown in Fig. 4.8, at steady state caveolin-1 is expressed at low levels in all the 
SI, while after infection we found that it is up-regulated. In detail, in the duodenum 
Salmonella infection induces an higher expression of cav-1 first in the blood vessels and 
then in the lymphatics, and its expression is restored at low levels after 24 hours p.i. On 
the contrary, in the jejunum and ileum, we found a higher expression of caveolin-1 both in 
the blood and lymphatic vessels at 2h and 6h p.i. In the ileum the presence of caveolae 
remains high also after 24 hours after infection. 
Together, these results suggest that Salmonella infection is able to modulate the 
formation of caveolae in intestinal blood and lymphatic vessels and to change the Plvap 
expression on blood vessels modifying the endothelial barrier state. 
 
4.1.5 Claudin-3 expression on intestinal epithelium after S. typhimurium infection 
 
Together with the modulation of Plvap expression, it was demonstrated that in the brain 
Wnt/β-catenin signaling pathway is also able to up-regulate the expression of Claudin-3 
(Cldn-3) resulting in barrier maturation (Liebner et al., 2008). Starting from these findings, 
we wondered whether also in intestinal vessels Cldn-3 is modulated after infecting mice 
with S. typhimurium. We found that Cldn-3 is not expressed by intestinal ECs but 
interestingly its expression is modulated by the infection in the epithelium confirming what 
has been recently demonstrated by Corr et al. (Corr et al., 2013). We showed that Cldn-3 
is up-regulated after infection especially after 6 hours p.i. in the duodenum and jejunum 
while in the ileum it is expressed at steady state while it is down-regulated after infection 
(Fig. 4.9). Moreover, at 2 hours after infection we found a more basolateral localization of 
Cldn-3 compared to the other time points where it is localized at cell-cell junctions.
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Figure 4.9: Claudin-3 expression on intestinal epithelial cells after S. typhimurium infection. Confocal 
microphotographs showing blood vessels (green, CD34), Cldn-3 (red) and DAPI (blue) in 10 µm thick 
cryosections from different tracts of the small intestine of C57/Bl6 mice at different time points after oral 
gavage with 109 S.typhimurium ΔAroA. Bars: 50 µm.  
 
 
4.1.6 Permeability of the intestinal blood vessels is modified by S. typhimurium 
infection 
 
To understand whether after S. typhimurium infection the vascular barrier function is 
compromised, we tested endothelial permeability injecting 2 mg of 20 KDa FITC-Dextran 
in intestinal loops exteriorized from C57/Bl6J mice orally infected with 109 S.typhimurium 
ΔAroA. At different time points after Salmonella infection blood was harvested and tested 
for the presence of the fluorophore. As controls, intestinal loops from mice not infected 
were injected with the fluorophore-conjugated dextran. We found an accumulation of 
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FITC-dextran in the blood serum between 4h and 24h after infection, when conjugated 
dextran is injected in the duodenum or jejunum, while if it is injected in the ileum it reaches 
the blood stream after 24h (Fig. 4.10).  
 
 
Figure 4.10: S. typhimurium infection modifies barrier properties of intestinal endothelium. C57/BL6 
mice were orally infected with 109 S.typhimurium ΔAroA and immediately or after 1h, 4h or 24h were 
anesthetized and in different parts of the SI, intestinal loops were exteriorized and ligated. 2 mg of FITC-
Dextran 20 KDa were injected in the loop. After 1h blood was harvested from the heart and tested for the 
presence of the fluorophore. As control, uninfected mice were injected in the duodenum, jejunum or ileum with 
FITC-Dextran and blood was collected after 1h. Serum fluorescence was measured by a fluorimeter and from 
each value the fluorescence of the serum collected from an untreated mice was subtracted to eliminate the 
basal level of fluorescence. Results represent mean±SEM. n=4, for each condition. Statistical significance was 
evaluated using Student unpaired t-test with Welch’s correction for unequal variances. ** p<0.01.  
 
 
To assess that the increased passage of dextran was not simply due to an increased 
epithelial permeability, we decided to assess the inside-out increased vessel permeability. 
We adapted the protocol described by Xu and colleagues (Xu et al., 2012) to the multi-
photon confocal microscope present in our imaging facility to our purpose to analyze the 
modification of intestinal vessels barrier properties. Briefly, following anesthesia, a loop 
from the ileum of untreated mice or mice infected for 4 hours with 109 S.typhimurium 
ΔAroA was externalized and the mucosa was exposed by making an incision avoiding 
blood loss. Just before imaging, FITC-dextran with different molecular weights were 
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microscopy for at least 10 min every 30 s. As control dye, 4 KDa FITC-dextran was used. 
As shown in Fig. 4.11 in both untreated and Salmonella treated mice, the loss of 
intravascular fluorescence was very rapid and the visualization of lamina propria blood 
vessels morphology was lost immediately after fluorophore injection since 4 KDa dextran 
was not retained but it was accumulated in the intestinal lumen. 
 
Figure 4.11: Intestinal vessels are highly permeable to 4 KDa FITC-Dextran. Intestinal blood vessels 
permeability to 4 KDa FITC-dextran was visualized by intravital 2-photon microscopy. 2 mg 4 KDa FITC-
Dextran were injected i.v. and intestine was immediately imaged. Time-lapse images were acquired every 30s 
for 10 min. Yellow arrows indicate fluorophore extravasation through the gut epithelium into the intestinal 
lumen. Scale bar: 20 μm. n = 3. 
 
 
On the contrary, if 70 KDa FITC-dextran was injected i.v. in untreated C57/BL6J mice, it 
remains almost completely within the vessel (Fig. 4.12, upper panels), while when mice 
were infected with Salmonella the fluorophore started to extravasate just after few 
seconds after starting the imaging (Fig. 4.12, lower panels). After infection, 70 KDa 
dextran was able to extravasate and also to pass the epithelium indicating that Salmonella 
is able to modify both epithelial cell permeability, as extensively demonstrated, but also 
vascular barrier permeability. 
 













Figure 4.12: Salmonella infection increases the vascular permeability to 70 KDa dextran. Intestinal 
blood vessels permeability to 70 KDa FITC-dextran was visualized by intravital 2-photon microscopy. 0.5 mg 
70 KDa FITC-Dextran were injected into the tail vein just before imaging in untreated or Salmonella infected 
mice (4h). Time-lapse images were acquired every 30s for 10 min. Yellow arrows indicate fluorophore exit 
from the vessels. Scale bar: 20 μm. n = 3. 
 
 
A ratiometric analysis of extra- versus intravascular fluorescent dye was also conducted to 
quantify the difference between the permeability to the dextrans with different molecular 
weight. At 10 min after dye injection, the relative fluorescence of 70KDa dextran injected 
in Salmonella infected mice is about 5.5-fold higher than the fluorescence of the same 
dextran injected into untreated mice. Conversely, the permeability of intestinal blood 
vessels to 4KDa dextran is equivalent between infected and non-infected mice (Fig. 4.13).  
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Figure 4.13: Ratiometric analysis of fluorescence intensity of extra- versus intravascular dextrans in 
untreated and Salmonella-infected mice. An area of 5×5 μm was chosen inside and outside the blood 
vessel. The fluorescence intensity was determined in the areas for both the FITC-dextrans in untreated and 
infected mice. For each time-point, the fluorescence intensity was measured for 10 areas inside and 10 areas 
outside the blood vessel and the ratio between the outside and the inside fluorescence intensity was 
calculated and normalized on the fluorescence ratio at time 0. The ratio was plotted in percentage over time. 
Results are represented as mean±SEM. Statistical significance was evaluated using 2-way ANOVA. * p<0.05.  
 
 
4.2 Mechanisms behind the intestinal endothelial barrier modifications 
 
4.2.1 Bacterial invasiveness is not involved in the changes of the intestinal 
endothelial barrier 
 
We have shown that S. typhimurium is able to modify the endothelial barrier properties in 
the gut and to colonize distal organs, such as liver and spleen. Therefore, we wondered 
whether this could be explained only by the capacity of Salmonella to cross the epithelial 
barrier and hence to reach the endothelial barrier or by the fact that Salmonella is able to 
actively modulate a signaling cascade necessary for the modification of the intestinal 
endothelial barrier. To answer to the first question we infected mice with a non-pathogenic 
strain of E. coli or with an E. coli strain made capable to cross the epithelial barrier by the 
expression of the Yersinia enterocolitica Inv protein (E. colipInv). 
Yersinia invasin, a protein of the outer membrane, has been demonstrated to be involved 
in the entry of the enteropathogenic bacterium into non-phagocytic cells through the 
binding to β1 integrin. The binding to the integrin activates the focal adhesion kinase and 
cytoskeletal proteins that lead to the formation of pseudopods that engulf the bacteria into 




Figure 4.14: E.coli as well as the invasive strain E.colipInv are not able to spread in the systemic 
circulation after oral administration. Mice were orogastrically inoculated with 109 E.coli (blue dots) or 
E.colipInv (red dots). After 2h, 6h, 24h and 48h CFUs in PPs, mLNs, spleen, liver, small intestine, divided into 
duodenum, jejunum, ileum, and colon were determined. Each data point represents an individual mouse. Error 




Although we were able to find E.coli expressing the Yersinia invasin in the duodenum, 
jejunum, ileum and colon meaning that it was able to cross the epithelial layer and to 
reach the intestinal lamina propria (Fig .14, lower panels) and few bacteria were also 
found in the PPs and in the mLNs, we did not find E.colipInv in the liver and spleen even 
after 48 hours p.i. (Fig 4.14, upper panels, red dots), meaning that, although it is invasive, 
E.colipInv is not able to disseminate systemically. As control, mice were infected with a 
non-pathogenic E.coli strain, which was found neither in the intestine nor in the mLNs, 
liver and spleen (Fig 4.14, blue dots). These data suggest that the capacity of Salmonella 
to cross the intestinal endothelium and to modify its barrier characteristics is not simply 
due to the fact that it is able to cross the gut epithelium and reach the underlying vessels 
Spleen































































































































































but to an active process probably involving the activation/repression of signaling pathways 
and/or modification of cell-cell junctions. 
 
4.2.2 S. typhimurium negatively regulates Wnt/β-catenin signaling pathway 
 
The second hypothesis that could explain the capacity of Salmonella to disseminate 
systemically is its ability to actively modify the intestinal endothelial barrier by modulating 
a signaling pathway. 
Canonical Wnt/β-catenin signalling pathway was demonstrated to be involved in vascular 
development in the embryo (Cattelino et al., 2003) and in particular in the formation of the 
blood-brain barrier. Indeed, at embryonic day 9.5 there is a marked activation of β-catenin 
in endothelial cells of brain capillaries which then decreases between days 15.5 and 17.5 
(Liebner et al., 2008). In the brain, the activation of β-catenin correlates with the down-
regulation of Plvap and maturation of the BBB. Moreover, it has been shown that Wnt/β-
catenin signaling pathway is involved in S. typhimurium infection in intestinal epithelial 
cells (Duan et al., 2007; Liu et al., 2010; Sun et al., 2005; Zhang et al., 2012). Thus, we 
hypothesized that β-catenin activation may be responsible for the establishment also of 
the “gut vascular unit” and that it could be regulated by S. typhimurium also in endothelial 
cells. To support this hypothesis, we used an in vitro system in which primary lung 
endothelial cells, isolated from C57/BL6 mice, were infected with S. typhimurium and the 
expression of Axin2 gene, one of the downstream targets of β-catenin, was analyzed by 
RT-PCR. We used primary lung endothelial cells for the in vitro experiments because of 
the lack of established mouse intestinal endothelial cell lines and we were not yet able to 
obtain a large number of primary murine intestinal endothelial cells and to propagate them 
in culture. We found that lung ECs infected with the Salmonella WT strain express less 
Axin2 compared to the Wnt3a treated cells, that has been used as positive control and 
compared to the untreated cells (Fig. 4.15). Lung ECs were also infected with mutated 
Salmonella strains, specifically a SPI-2 deleted strain (BA83), a noninvasive SPI-1 mutant 
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strain (BA34) or an endotoxin mutant (FB61, msbB). Only when cells were infected with 
BA83 strain the down-regulation of Axin2 was abrogated (Fig. 4.15) indicating that 
probably proteins encoded by T3SS pathogenicity islands 2 are involved in blocking the 
activation of the Wnt/β-catenin signaling pathway in the endothelium. Moreover, we 
infected ECs also with WT E. coli strain or an invasive E.coli strain (DH5αpInv). Analyzing 
Axin2 expression levels, only the invasive E. coli strain but not the non-pathogenic one is 
able to reduce the activation of β-catenin (Fig. 4.15). 
 
Figure 4.15: Wnt/β-catenin signaling pathway activation state after infection with different strains of S. 
typhimurium and E. coli. Primary lung endothelial cells were infected with WT S.typhimurium (FB62), a SPI-
2 deleted strain (BA83), a noninvasive SPI-1 mutant strain (BA34), an endotoxin mutant (FB61, msbB) or with 
a WT DH5α E. coli strain or a modified strain expressing invasin from Y. enterocolitica. Cells were infected 
with a MOI 1:10 for 1h, washed and left with medium containing gentamycin for 90 min. Alternatively, cells 
were treated with 100 ng/ml of recombinant Wnt3a as positive control. Cells were then lysed and expression 
of Axin2 was assessed by RT-PCR. Results are pooled from 3 independent experiments. Results represent 
mean±SEM. Statistical significance between untreated (PBS) and treated samples was evaluated using two-
tailed Student’s t-test. *p<0.05, **p<0.01, ***p<0.001.  
 
 
In the in vivo experiment, shown in Figure 4.14, we found that E.colipInv was not able to 
disseminate systemically and therefore we were expecting that, unlike S. typhimurium, 







































invasive E.coli should not be able to down-regulate Axin2. However, we unexpectedly 
observed that E.colipInv is able to down-regulate Axin2 although to a lower extent than S. 
typhimurium (Fig. 4.15). These results suggest that S. typhimurium and an invasive strain 
of E. coli, at least in vitro, are able to affect the translocation of β-catenin to the nucleus 
where it binds lymphoid enhancer factor (Lef)/T cell factor (TCF) and modulates the 
transcription of target genes, such as Axin2. It remains to be established whether Axin2 
can be considered as the best marker of all of the target genes of Wnt signaling and 
whether the two bacteria control differently the Wnt pathway and hence a panel of target 
genes should be analyzed to have a complete picture. In addition, it would be interesting 
to know whether the difference in the downregulation of Axin2 in response to Salmonella 
or E. colipInv can account for the different behavior of the two bacteria in vivo. Moreover, it 
seems that TTSS SPI-2 is involved in the modulation of β-catenin activity. The possible 
implication in vivo could be that infection with Salmonella reduces the stability of β-catenin 
in the intestinal endothelium consequently inducing the up-regulation of Plvap and, in 
general, the destabilization of the barrier to favour its systemic spreading. 
 
4.2.3 MyD88 signaling regulates β-catenin activation state in endothelial cells  
 
Toll-like receptors (TLRs) act as primary sensors for microbial components whose 
engagement by the bacterial ligands culminates with the activation of the transcription 
factor nuclear factor-kappaB (NF-kappaB). The endothelial cells express a number of 
TLR, such as TLR2, 3, 4 and 6 in the brain endothelium (Nagyoszi et al., 2010) or TLR4 
(Ogawa et al., 2003) and 5 (Maaser et al., 2004) in the intestinal endothelial cells. Once 
vascular endothelial cells are stimulated by LPS, they become activated and are 
characterized by an enhanced expression of cell adhesion molecules (CAM) with an 
increased leukocyte adhesion and tissue recruitment from the circulation (Ogawa et al., 
2003). 
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In epithelial cells, Salmonella is known to activate upon TLR engagement both the pro-
inflammatory NF-κB signaling pathway and the β-catenin signaling pathway. Moreover it 
has been demonstrated a direct physical interaction between the NF-κB p50 subunit and 
β-catenin upon infection (Duan et al., 2007; Sun et al., 2005). 
Since we have shown that S. typhimurium infection induces the reduction of β-catenin 
activation (Fig 4.16) in endothelial cells we wondered whether this modulation is mediated 




Figure 4.16: TLR4 engagement in endothelial cells is not required for Wnt/β-catenin signaling 
pathway. Primary lung endothelial cells from WT or TLR4-deficient mice were infected with WT S.typhimurium 
(FB62), a SPI-2 deleted strain (BA83), a noninvasive SPI-1 mutant strain (BA34), an endotoxin mutant (FB61, 
msbB) or with a non-pathogenic (DH5α) or invasive (DH5αpINV) E. coli strains. Cells were infected with a MOI 
1:10 for 1h, washed and left with medium containing gentamycin for 90 min. As positive control, cells were 
treated with 100 ng/ml of recombinant Wnt3a. Cells were then lysed and expression of Axin2 was assessed 











































For this purpose, primary lung endothelial cells isolated from WT, TLR4 KO and MyD88 
KO mice were infected with WT Salmonella or mutated strains for SPI-2, SPI-1 or 
endotoxin or with E. coli WT or invasive strains and Axin2 expression was evaluated as 
indicator of β-catenin activation. As shown in Fig. 4.16, TLR4 ligation is not involved in the 
reduced activation of β-catenin that we observed with WT lung endothelial cells. However, 
the effect seemed to be mediated by the signal transduction protein MyD88 since the 
canonical Wnt/β-catenin signaling pathway is completely shut off in MyD88 deficient 
endothelial cells (Fig. 4.17). Interestingly, the absence of MyD88 in endothelial cells 
induces the reduction of β-catenin activation even in the absence of TLR ligands or in 
presence of the Wnt3a, known to activate the Wnt/β-catenin pathway and therefore the 
transcription of Axin2 (Fig. 4.17).  
 
Figure 4.17: β-catenin activation after infection in endothelial cells is dependent on MyD88. Primary 
lung endothelial cells from WT or MyD88 KO mice were infected with WT S.typhimurium (FB62), a SPI-2 
mutated strain (BA83), a noninvasive SPI-1 mutant strain (BA34), an endotoxin mutant (FB61) or with a WT 
DH5α E. coli strain or a modified strain expressing invasin from Y. enterocolitica. As control for the β-catenin 
activation state, cells were treated with 100 ng/ml of recombinant Wnt3a. ECs were then lysed and expression 
of Axin2 was assessed by RT-PCR. Results represent mean±SEM. Statistical significance between WT and 












































This effect is confirmed also by analyzing the expression of Plvap, another gene inversely 
modulated by the activation of β-catenin in endothelial cells. Indeed, as shown in Fig. 
4.18, MyD88 deficiency caused the up-regulation of Plvap gene independently from the 
presence of bacteria and Wnt ligands.  
These preliminary results suggest an unknown interaction between β-catenin and MyD88 
adaptor protein. An explanation for the interaction between MyD88 and β-catenin could be 
that MyD88 is important to maintain a basal level of active β-catenin that could be 
involved in the maintenance of endothelial barrier similarly to what happens for the 
intestinal epithelium in which Wnt/β-catenin signaling is important for the maintenance of 
intestinal homeostasis (Fevr et al., 2007). MyD88 is downstream of most TLRs and of IL-
1/IL-18 signaling pathways (Warner and Nunez, 2013). Hence, basal activation of β-
catenin may be the response of either IL-1 signaling or endogenous ligands of TLRs via 
MyD88.  
Moreover during infection it has been shown that MyD88 plays an important role in 
controlling the systemic spreading of C. rodentium (Gibson et al., 2008) that could be 
















































Figure 4.18: Plvap expression after infection of endothelial cells is dependent on MyD88. Primary lung 
endothelial cells from WT or MyD88 KO mice were infected with WT S.typhimurium (FB62), a SPI-2 (BA83), 
SPI-1 (BA34), or endotoxin (FB61) mutated strains or with DH5α E. coli or invasin-expressing strains. As 
control for the β-catenin activation state, cells were treated with 100 ng/ml of recombinant Wnt3a. ECs were 
then lysed and expression of Plvap was assessed by Real Time-PCR. Results represent mean±SEM. 
Statistical significance between WT and KO samples was evaluated using two-way ANOVA test. ***p<0.001.  
 
 
4.2.4 Wnt/β-catenin signaling pathway controls Salmonella systemic spreading in 
vivo 
 
To assess the role of β-catenin in the formation of the gut-vascular barrier in vivo, we 
used a mouse line in which β-catenin is active specifically in endothelial cells in an 
inducible way. In β-cateninlox(ex3)/lox(ex3) mice, the exon3 of the β-catenin gene (Catnb), that 
contains the serine/threonine residues phosphorylated by the GSK3β kinase, is flanked by 
two LoxP sites (Harada et al., 1999). These mice were crossed with Cdh5(PAC)-CreERT2 
mice where Cre recombinase is inserted downstream of VE-cadherin (Cdh5) promoter 
(Monvoisin et al., 2006). Upon tamoxifen treatment the Cre recombinase is expressed in 
VE-cadherin positive endothelial cells and the β-catenin exon3 is excised resulting in a 
gain-of-function (GOF) mouse strain, i.e. where β-catenin becomes constitutively active. 
We decided to use this mouse line and not a mouse line in which β-catenin is activated in 
all the tissue because in the intestine β-catenin is known to be involved in intestinal 
epithelial cell proliferation and differentiation (Fevr et al., 2007; Pinto et al., 2003) and also 
because we wanted to assess the role of β-catenin activation only in endothelial cells as 
Salmonella affects β-catenin activation in epithelial cells (Liu et al., 2010; Zhang et al., 
2012). 
Hence, we infected intragastrically Cdh5(PAC)-CreERT2 X β-cateninlox(ex3)/lox(ex3) GOF mice 
with 109 S. typhimurium ΔaroA. Before starting the experiments, excision of exon3 was 
verified by PCR (see Materials and Methods section). 
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Figure 4.19: S. typhimurium systemic spreading is reduced in β-catenin gain-of-function mice. 
Cdh5(PAC)-CreERT2 X β-cateninlox(ex3)/lox(ex3) GOF mice or β-cateninlox(ex3)/lox(ex3) control mice were infected 
p.o. with 109 S.typhimurium ΔaroA. After 2h, 6h and 24h CFUs in PPs, mLNs, spleen, liver, small intestine and 
colon were determined. Each data point represents an individual mouse. Error bars represent SEM. Results 
are representative of 2 independent experiments with similar results. Student unpaired t-test with Welch’s 
correction for unequal variances was used to determine statistical significance. *P<0.05. 
 
 
If β-catenin is involved in modulating the endothelial barrier in the gut, we expect that 
when β-catenin is made constitutively active, the barrier integrity should be maintained 
and therefore Salmonella should not be able to spread systemically. 
As expected, we found that S. typhimurium was able to invade and colonize different 
segments of the small intestine and colon of GOF mice and Cre-negative control mice in 
the same way (Fig. 4.19, lower panels), indicating that the constitutive activation of β-
catenin in endothelium did not have indirect effects on intestinal epithelium permeability. 
However, between 6h and 24h when there was the highest number of CFU in the liver of 
control mice, we found fewer bacteria in the livers of GOF mice. The same result was 
obtained also for the spleen at 24h post infection (Fig. 4.19, upper panels). These data 









































































































































the endothelial barrier and spread systemically indeed it cannot reach either the liver or 
the spleen crossing the intestinal blood vessels but it can only reach the mLNs (Fig. 4.19, 
upper panels) by the lymphatics where probably it will remain confined  (Voedisch et al., 
2009). 
 
4.2.5 Permeability of the intestinal blood vessels is modified by S. typhimurium 
infection 
 
To assess the functionality of the intestinal barrier in Cdh5(PAC)-CreERT2 X β-
cateninlox(ex3)/lox(ex3) GOF mice at steady state and after challenge with S. typhimurium, we 
tested endothelial permeability injecting 2 mg of 20 KDa FITC-conjugated dextran in 
intestinal loops exteriorized from Cre+ GOF mice and Cre- control mice orally infected with 
109 S.typhimurium ΔAroA.  
 
Figure 4.20: S. typhimurium do not modifies endothelial permeability of intestinal blood vessels of 
Cdh5(PAC)-CreERT2 X β-cateninlox(ex3)/lox(ex3) gain-of-function mice. Cdh5(PAC)-CreERT2 X β-
cateninlox(ex3)/lox(ex3) GOF mice and cre-negative control mice were orally infected with 109 S.typhimurium 
ΔAroA and after 4h or 24h were anesthetized and intestinal loops were exteriorized and ligated. 2 mg of FITC-
Dextran 20 KDa were injected in the loop. After 1h blood was harvested from the heart and tested for the 
presence of the fluorophore. As control uninfected mice were injected in the duodenum, jejunum or ileum with 
FITC-Dextran and blood was collected after 1h. Serum fluorescence was measured at fluorimeter and from 
each value the fluorescence of the serum collected from naive mice was subtracted to eliminate the basal 






























































































level of fluorescence. Results represent mean±SEM. Statistical significance was evaluated using Student 
unpaired t-test with Welch’s correction for unequal variances. *p<0.05, ns: not significant.  
 
 
Analyzing the fluorescence in the blood serum we found an accumulation of FITC-Dextran 
at 4h after infection, when conjugated dextran was injected in the duodenum or jejunum of 
cre recombinase negative control mice, as expected from the previous experiments (Fig. 
4.10), but not in the β-catenin GOF mice where permeability to the 20 KDa dextran is not 
modified even after infection (Fig. 4.20). In contrast, when fluorophore-conjugated dextran 
was injected in ligated ileum in all time points analyzed there was only a slight difference 
between GOF and control mice (Fig. 4.20). Moreover, we noticed a difference between 
the results of the permeability experiments carried out with Cre- control mice and the WT 
C57/BL6J mice (purchased from Harlan) when FITC-dextran was injected in the ileum. 
This discrepancy could be explained taking into account the fact that the ileum is most 
colonized part of the small intestine by the intestinal microbiota and that it is highly 
possible that the composition of the intestinal flora is different between animals bred in our 
animal facility and mice purchased from an external company, indicating a possible role of 
the microbiota in the modulation of vascular barrier function in the gut. It is likely that a 
different composition of the microbiota may modify the epithelial (for example by 
modulating Cldn-3 expression) and/or endothelial barrier, thus influencing the segment of 
the intestine that is more prone to be invaded by Salmonella. 
All together these results suggest that Salmonella influences β-catenin activation state in 






4.3 Role of microbiota in GVU formation 
 
4.3.1 Colonization of the intestine by the microbiota induces barrier maturation 
 
The intestinal microbiota exerts a multiplicity of functions in our body such as nutrient 
absorption, xenobiotic metabolism, angiogenesis, maturation of the immune system and 
plays a key role in the intestinal barrier maturation (Hooper et al., 2001; Natividad and 
Verdu, 2013). Another uninvestigated role of the intestinal flora could be to induce the 
formation of the GVU during the postnatal period and to maintain vascular barrier integrity 
during adulthood.  
To understand the role of gut microbiota in the establishment of vascular barrier we 
analyzed the presence of bacteria in the organs of C57/BL6 mice after weaning when the 
switch from lactation to solid food is known to change the bacterial composition of the 
offspring gut. We tested different time points after weaning but we found the highest 
difference between day 8 and day 10 post-weaning. We found that at day 8 some bacteria 
of the intestinal flora reached both the mLNs and the liver, while at day 10 we did not find 
any bacteria in both organs (Fig. 4.21). 
 
Figure 4.21: Intestinal vascular barrier became mature after weaning. C57Bl/6 mice were weaned and 
after 8 or 10 days bacterial number in the mLNs and liver were evaluated. Each data point represents an 





































These results suggest that in the early phases of life, the GVU can be modified by the diet 
(from breast milk to solid food) and/or by the gut microbiota that may be participating in 
the formation and maturation of the intestinal barrier. However, till now we cannot clearly 
dissect out the role of the microbiota on epithelial and on endothelial barrier maturation.  
Another interesting aspect of the relationship between the intestinal microbiota of the 
offspring and pregnancy is the exchange of bacteria between the maternal gut and the 
newborn. Indeed, although it is commonly accepted that the intrauterine environment is 
sterile, it has been reported the presence of bacteria in the intrauterine environment that 
are probably involved in the prenatal colonization of the newborn. Enterococcus, 
Streptococcus, Staphylococcus, or Propionibacterium bacterial genera were found in the 
umbilical cord blood suggesting translocation of the mother’s gut bacteria via the 
bloodstream (Jimenez et al., 2005; Matamoros et al., 2013). Moreover, another strong 
influence in the development of the newborn intestinal microbiota is breast milk. In fact, in 
breast milk bacterial strains from Streptococcus and Staphylococcus genera were isolated 
(Fernandez et al., 2013; Matamoros et al., 2013). How the maternal gut microbiota 
reaches the newborn via umbilical cord blood or via the milk through the lactating gland is 
unknown. In both cases, a role for dendritic cells has been hypothesized (Fernandez et 
al., 2013; Jimenez et al., 2005), but another possibility could be that during pregnancy the 
maternal gut-vascular barrier may be more permissive to the microbiota.  
To test this hypothesis we harvested the intestine of female mice as soon as the offspring 
were weaned and we stained them for Plvap molecule that we have identified as marker 





Figure 4.22: Plvap expression on intestinal blood vessels of lactating females. Confocal images 
showing blood vessels (green, CD34), Plvap (red) and DAPI (blue) in cryosections from duodenum, jejunum 
and ileum of C57/BL6 female mice at the end of lactation. Bars: 30µm.  
 
 
Analyzing the small intestine of lactating females, we found that Plvap is expressed in the 
duodenum and at lower levels in the jejunum (Fig. 4.22), while in normal mice we have 
previously shown that at steady state Plvap is not express in any part of the small 
intestine. Although this is still only a preliminary result, it may indicate that during 
pregnancy the intestinal vascular barrier could be more permeable explaining why the 
microbiota is found in the systemic circulation or in the mammary gland. 
 
4.3.2 Antibiotic treatment increases S. typhimurium systemic spreading 
capabilities 
 
Another possible role of the microbiota is to maintain the GVU integrity in order to 
preserve the health of our body. 
For this reason we treated mice with broad spectrum antibiotics (ampicillin, vancomycin, 
neomycin sulfate and metronidazole) for 4 weeks before challenging them with 




Figure 4.23: S. typhimurium spreading after antibiotic treatment. C57/BL6 mice received in the drinking 
water a mixture of antibiotics (Abx) to eliminate most of the endogenous microbiota (ampicillin, metronidazole, 
neomycin, vancomycin). After 4 weeks, mice were inoculated p.o. with 109 S.typhimurium ΔaroA bacteria. 
After 2h or 6h CFUs in PPs, mLNs, spleen and liver were determined. Each data point represents an 
individual mouse. Error bars represent SEM. Results are pooled from 2 independent experiments. Student 
unpaired t-test with Welch’s correction for unequal variances *P<0.05, **P<0.01. 
 
 
As shown in Fig. 4.23, antibiotic treatment resulted in an increase in the translocation of 
Salmonella to the liver and spleen. This result suggests that the reduced number of the 
microbiota present into the intestine after antibiotic treatment could bring the gut vascular 
barrier to an immature state which is more permissive for Salmonella entry. However, we 
cannot exclude that the increased translocation of bacteria after antibiotic treatment is 
also due to a higher ability of Salmonella to penetrate the epithelial barrier in the absence 





































































































In this work we have identified an intestinal vascular barrier that controls the systemic 
dissemination of food antigens and invasive bacteria that can be either accidentally 
ingested with the diet or be resident within the microbiota. 
Drawing a parallel between the well-known BBB and the newly identified gut vascular 
barrier (GVB) many similarities can be found. For both of them, the body has evolved a 
set of mechanisms to avoid the indiscriminate movement of molecules, cells and bacteria 
from blood to the brain parenchyma in the BBB and from the subepithelial space to the 
blood in the case of the GVB. However, the BBB and GVB display different characteristics 
due to the fact that these two endothelia should fulfill distinct functions. For instance, the 
BBB should avoid the uncontrolled movement of any substances from the blood into the 
brain parenchyma to protect the CNS from the constantly changing milieu of the blood 
stream. For this reason, the brain endothelium is continuous, paracellular trafficking is 
avoided by TJs, transcytosis is limited and the controlled movement of substances is 
achieved by the polarized expression of transporters (Abbott et al., 2006; Siegenthaler et 
al., 2013). By contrast, the intestinal endothelium is not continuous and it should be 
permeable to nutrients, due to the absorptive function of the gut. However, it displays 
barrier characteristics to preserve the body from the spreading of intestinal microbiota and 
pathogens that could cross the epithelium and has size limit exclusion to large molecules.  
Indeed molecules with low molecular weight can diffuse via the paracellular route while 
high molecular weight molecules can be transported by transcytosis. The paracellular 
trafficking of molecules with high molecular mass is avoided by the presence of TJs and 
AJs proteins at cell-to-cell junctions. 
We found that, similar to the cerebral endothelium, intestinal ECs express the main 
components of TJs (occludin, JAM-A, Cldn-12, as well as the cytoplasmic proteins ZO-1 
and cingulin) and AJs (VE-cadherin and junctional β-catenin). Moreover, in line with 
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previous studies that have demonstrated that there is an extensive network of glial cells 
within the LP with processes that reach the epithelial cell layer (Bush et al., 1998; Neunlist 
et al., 2007; Neunlist et al., 2008) and blood capillaries (Hanani and Reichenbach, 1994), 
we found that in the mouse gut, enteric glial cells (the equivalent of astrocytes in the brain) 
entail contacts with blood vessels, particularly when they are located in proximity to the 
epithelium. Different studies have highlighted the importance of enteric glial cells in the 
intestine. Indeed mice lacking GFAP+ cells died for fulminant jejuno-ileitis characterized by 
massive destruction of the epithelial layer together with microvascular disturbances that 
result in bacterial spreading into the blood (Bush et al., 1998). Enteric glia was found to 
regulate mucosal barrier function secreting S-nitrosoglutathione (Savidge et al., 2007) 
which induces an increased expression of ZO-1 and occludin in the epithelium (Flamant et 
al., 2011). Whether gut glial cells may confer a barrier phenotype also to intestinal ECs, 
resembling the astrocytes in the brain, is still unknown. This possibility is however 
supported by the finding that transplantation of enteric glia into the damaged spinal cord 
accelerates the repair of vasculature at the site of injury and the induction of barrier 
properties (Jiang et al., 2005). 
Gut ECs were found associated also to pericytes that together with enteric glial cells form 
what we call “gut vascular unit” (GVU). However the influence of these cells on the ECs 
barrier phenotype remains to be established. 
 
We hypothesize that the role of the GVB is to exclude from the systemic circulation 
bacteria or other unwanted molecules that have been translocated from the gut lumen. To 
define clearly whether there is a functional vascular barrier we analyzed the expression of 
Plvap protein as barrier marker. 
Different reports have demonstrated that in the BBB, Plvap is a marker of “leaky” vascular 
barriers (Armulik et al., 2010; Daneman et al., 2010) and Liebner et al. have found that 
Wnt/β-catenin signaling pathway activation is responsible for the down-regulation of Plvap 
expression on ECs during barrier maturation (Liebner et al., 2008). 
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Analyzing the expression of Plvap in the intestinal blood vessels we found that it is not 
expressed at steady state but it is up-regulated in the jejunum, ileum and to a smaller 
extent in the duodenum upon infection with S. typhimurium following the same kinetics of 
Salmonella spreading to the liver. This is in accordance with the observation that in vitro 
Salmonella is able to reduce β-catenin activation and therefore could induce Plvap up-
regulation. Moreover, we found that TTSS encoded by pathogenicity islands 2 are 
involved in blocking the activation of the Wnt/β-catenin signaling pathway in the 
endothelium since TTSS-2 mutated strain fail to down-regulate Axin2, used as marker of 
Wnt/β-catenin signaling pathway activation.  
Interestingly, Cirillo et al. have found that SPI-2 mutants are able invade PPs but were not 
found in the mLNs, liver and spleen and this was linked to the fact that SPI-2 is required to 
avoid Salmonella clearance by macrophages (Cirillo et al., 1998). In light of our results, 
the inability of TTSS-2 mutant to spread systemically could also be due to the fact that 
they are not able to pass the intestinal endothelium and reach the blood stream.  
Moreover, we found that an E.coli strain expressing Y. enterocolitica invasin gene was 
able to reduce the activation of β-catenin although it was not able to disseminate 
systemically in vivo. These results suggests that other Wnt/β-catenin target genes should 
be analyzed to have a complete picture and to be sure that Axin2 can be considered as 
the best marker of all of the target genes of Wnt signaling. Another possibility is that the 
difference between the behavior of Salmonella or E. colipInv can be in the modulation of 
other signaling pathways. 
The involvement of the Wnt/β-catenin signaling pathway in maintenance of the integrity of 
the GVB is demonstrated also by the experiments carried out with Cdh5(PAC)-CreERT2 X 
β-cateninlox(ex3)/lox(ex3) mice where, upon tamoxifen treatment, β-catenin becomes 
constitutively active in endothelial cells. We used this mouse line and not a mouse line in 
which β-catenin is activated in all the tissue because in the intestine β-catenin is known to 
be involved in intestinal epithelial cell proliferation and differentiation (Fevr et al., 2007; 
Pinto et al., 2003) and also because we wanted to assess the role of β-catenin activation 
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only in endothelial cells as Salmonella affects β-catenin activation in epithelial cells (Liu et 
al., 2010; Zhang et al., 2012). Using these mice we found that when β-catenin is activated 
in vascular ECs, S. typhimurium is not able to spread systemically indeed it cannot reach 
either the liver or the spleen crossing the intestinal blood vessels. However, Salmonella 
can still reach the mLNs by the lymph but does not recirculate through the thoracic duct 
into the blood circulation since mLNs work as “firewall” (Hooper and Macpherson, 2010) 
(Macpherson and Smith, 2006). Thus the mLN firewall can limit also pathogen spreading 
to systemic sites.  
Together with the down-regulation of the “leaky” protein Plvap, the BBB acquires the 
expression of tight junction proteins during the establishment of endothelial barrier 
function. These proteins include Cldn-5 (Nitta et al., 2003) and Cldn-3 whose expression 
is increased by Wnt/β-catenin pathway activation in ECs (Liebner et al., 2008). 
Analyzing the expression of these proteins in the intestine we found that Cldn-5 is only 
expressed in the lymphatics while Cldn-3 is not expressed in the ECs. However, we found 
that Cldn-3 is expressed by the epithelial layer and its expression and cell localization are 
modulated by Salmonella infection in line with what has been recently demonstrated by 
Corr et al. (Corr et al., 2013). The importance of Cldn-3 in the establishment of epithelial 
barrier function has been demonstrated also by the study on probiotics by Patel et al. 
Indeed, the treatment of neonatal mice that show an immature epithelial barrier, with 
Lactobacillus rhamnosus GG induces an increased expression of Cldn-3 in the epithelium 
and the maturation of barrier function (Patel et al., 2012). Interestingly, the authors pointed 
out that this probiotic strain has a protective function at low doses while the administration 
of a high dose of live probiotic induces death of the animals because of sepsis. This 
suggests that neonatal mice, beyond an immature epithelial barrier, could have also an 
immature vascular barrier still permeable to bacteria. 
Patel and colleagues have also shown that the maturation of the intestinal epithelium is 
abrogated in MyD88-/- mice indicating that MyD88-dependent TLR signaling may play a 
role in inducing intestinal barrier function (Patel et al., 2012). We suspected that MyD88 
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could also be involved in the maintenance of the GVB. Indeed, we found that the absence 
of MyD88 in endothelial cells induced the reduction of β-catenin activation concomitantly 
with the up-regulation of Plvap gene even in the absence of exogenous TLR or Wnt 
ligands indicating that MyD88 is required in ECs for the maintenance of endothelial barrier 
properties (or at least for the inhibition of “leaky” proteins like Plvap), via a still unknown 
mechanism.  
The importance of MyD88 in the control of the permeability of the gut vascular 
endothelium together with a role in the maintenance of the epithelial barrier integrity is 
suggested by different studies in which MyD88-deficient mice show higher susceptibility to 
C. rodentium infection compared to WT controls – the bacterium was clearly identified 
inside the blood vessels of KO mice – (Gibson et al., 2008) and higher susceptibility to 
DSS-induced colitis, although the pathology seems to be not directly associated to 
bacteremia but to a compromised expression of cytoprotective factors by MyD88-/- 
epithelium (Rakoff-Nahoum et al., 2004). Additionally, it was found that the lack of MyD88 
adapter-like (Mal) protein on non-hematopoietic cells induces increased susceptibility to 
oral infection with S. typhimurium. Furthermore, Mal-deficient mice show perturbed barrier 
function with increased systemic spreading of Salmonella and increased blood 
permeability following infection (Corr et al., 2013).  
During the early phase of BBB breakdown, blood vessels in the site of lesion express 
another marker of leaky endothelial barrier, namely caveolin-1 (Nag et al., 2007), which 
has been associated to caveolae. Interestingly, in organs with fenestrated vessels like the 
intestine, Plvap protein was found localized at stomatal diaphragms of fenestrae and 
caveolae and it was found to be important for the maintenance of the endothelial barrier 
function (Herrnberger et al., 2012b; Stan et al., 1999; Stan et al., 2012). 
It has been demonstrated that caveolae are involved in the entry of viruses and bacteria 
such as E.coli K1 and Salmonella (Hoeke et al., 2013; Lim et al., 2010). In particular, it 
has been shown that Salmonella can down-regulate caveolin-2 expression by increasing 
the expression of miR-29a both in vivo and in vitro (Hoeke et al., 2013). In the small 
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intestine we found that caveolin-1 was expressed in blood vessels and in lymphatics and 
interestingly, we found that after infection it is up-regulated in both of them. The 
expression of caveolin-1, and therefore the increase in caveolae formation, could be 
another way by which Salmonella could spread in both the lymph and the blood.  
Together with the increase of caveolin-1 and of Plvap we functionally tested the presence 
of endothelial barrier using fluorophore-conjugated dextrans. Two approaches have been 
used: an “outside-inside” method in which dextran was injected into ligated intestinal loops 
and the presence of dextran in the serum was measured and an “inside-out” approach in 
which dextrans with different molecular weight were injected i.v. and the extravasation of 
the dextrans was visualized using 2-photon microscopy. 
Using both methods it was clear that Salmonella infection could reduce the functionality of 
the intestinal vascular barrier. In particular, using 2-photon microscopy we found that 
under steady state the GVB was permeable to 4KDa dextran but not to 70KDa dextran, 
indicating that the endothelial barrier in the intestine did not restricts the trafficking of small 
molecules – unlike the BBB in which the size exclusion is for molecules with molecular 
mass higher than 500 Da (Pardridge, 2005). However, the size exclusion limit of the GVB 
has to be identified. 
Using the same experimental set up, we assessed also the functionality of the intestinal 
barrier in Cdh5(PAC)-CreERT2 X β-cateninlox(ex3)/lox(ex3) GOF mice at steady state and after 
challenge with S. typhimurium. As expected, we found that in mice with a constitutively 
active β-catenin, ECs permeability to the dextran is not modified even after infection. 
Interestingly, we noticed a difference in the permeability to dextran of the ileal endothelium 
in Cre- control mice and WT C57/BL6J mice (purchased from Harlan). This discrepancy 
could be explained taking into account the fact that the composition of the intestinal flora 
is different between animals bred in our animal facility and mice purchased from an 
external company, indicating a possible role of the microbiota in the modulation of 
vascular barrier function in the gut. It is possible that components of the microbiota may 
modify both the endothelial barrier and the epithelial one. For instance, microbiota could 
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modulate Cldn-3 expression in the epithelium so that higher expression of Cldn-3 in the 
ileum could tighten the epithelial barrier avoiding the trafficking of molecules in the last 
part of the intestine. This modulation cannot be excluded since we have found a 
modulation of Cldn-3 expression by S. typhimurium. Indeed we showed that Cldn-3 is up-
regulated in the duodenum and jejunum and down-regulated in the ileum during infection. 
The down-regulation of Cldn-3 in the ileum could induce an increased epithelial 
permeability in this intestinal tract and it could be also possible that this favours DCs to 
sample luminal antigens extending their dendrites through the epithelial layer, in 
accordance to what was found by Chieppa et al. who showed an increased number of 
dendrites in the ileum upon Salmonella infection (Chieppa et al., 2006) (Fig. 5.1).  
Of note, although the results of “outside-inside” permeability assays could be influenced 
by the presence of another barrier – the epithelium – with the 2-photon experiments where 
an “inside-outside” method was used, we could analyze the effect of Salmonella on 















Figure 5.1 Scheme of the findings of this work. We have shown that at steady state Plvap is not expressed 
in the endothelial cells of the small intestine similarly to Caveolin-1, which is low express in the blood vessels. 
Upon infection both proteins were up-regulated mostly in blood vessels of the jejunum and ileum. Reducing 
the integrity of the endothelial barrier in these parts of the SI, Salmonella could favour its systemic spreading. 
Moreover, at steady state we found high expression of Cldn-3 in the epithelial layer of the ileum but not in the 
duodenum and jejunum. During S. typhimurium infection, Cldn-3 expression is up-regulated in the duodenum 
and jejunum and down-regulated in the ileum where the epithelial barrier could be less tight than the steady 
state. It could be possible that this could favour luminal antigens sampling by DCs extending their dendrites 
through the epithelial layer, in accordance to what was found by Chieppa et al. who showed an increased 
number of dendrites in the ileum upon Salmonella infection. 
 
 
Since the intestinal microbiota was shown to play a key role in the intestinal barrier 
maturation (Hooper et al., 2001; Natividad and Verdu, 2013) we wondered whether it 
could induce also the formation of the GVB during the postnatal period and maintain 
vascular barrier integrity during adulthood. Preliminary data show that soon after weaning 
the epithelial and/or endothelial barrier are not yet formed since we found intestinal 
bacteria in the liver and mLNs. However, after 10 days post-weaning we did not find any 
bacteria in these organs indicating that the endothelial barrier maturation can be induced 
by the gut microbiota, although we cannot exclude the contribution of the diet (from breast 
milk to solid food). Moreover, till now we cannot clearly dissect out the role of the 
microbiota on epithelial and on endothelial barrier maturation.  
On the other hand, the role of the microbiota in the maintenance of the GVB during 
adulthood was addressed treating mice with broad-spectrum antibiotics before challenging 
with S.typhimurium. We found that antibiotic treatment resulted in an increase in the 
translocation of Salmonella to the liver and spleen suggesting that the reduced number of 
the microbiota could modify the gut vascular barrier so that it is more permissive for 
Salmonella entry. However, we cannot exclude that the increased translocation of bacteria 
after antibiotic treatment is also due to a higher ability of Salmonella to penetrate the 
epithelial barrier in the absence of competing microbiota.  
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The importance of the intestinal endothelial barrier was also suggested by studies on 
human diseases. For instance, it was shown that one feature of IBD is the increased 
intestinal vascular permeability that leads to tissue edema and damage (Oshima et al., 
2001). Interestingly, the alteration of the vascular permeability in IBD patients is not 
restricted to the intestinal vessels but affects also the vasculature of other organs such as 
the brain (Hathaway et al., 1999). 
Furthermore, it has been found that in neonates, non-typhoidal Salmonella spp (included 
S. typhimurium serovar) that are usually able to cause only local infection, could cause 
bacteriemia and meningitis (van Sorge et al., 2011), suggesting that during infancy the gut 
endothelial barrier is still permeable and also non-typhoidal Salmonella spp are able to 
spread systemically and reach the brain. Another possibility is that in neonates the 
intestinal endothelium has not yet acquired some characteristics that can be involved in 
the discrimination between typhoidal and non-typhoidal Salmonella enterica serovars. 
 
In conclusion, we have identified and characterized the gut vascular barrier and we have 
shown that it plays a fundamental role in controlling the spreading of molecules and 
bacteria to systemic sites. To have a complete picture of the features of this newly 
discovered barrier we will analyze the gene expression profile of mouse isolated intestinal 
ECs with a next-generation sequencing approach. 
Moreover, we showed that Salmonella typhimurium infection could modify GVB integrity. 
One way by which S. typhimurium is able to modify the barrier properties of the intestinal 
blood vessels is through the negative regulation of the Wnt/β-catenin signaling pathway. 
In vitro we have identified the TTSS-2 as the possible negative regulator of the β-catenin 
signaling pathway, therefore in next future we will investigate the role of TTSS-2 in vivo. 
Another interesting point that we would like to examine in depth is the role of the 
microbiota in the maturation and maintenance of the GVB. To this aim we will analyze the 
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barrier properties in the endothelium of newborns, before and after weaning and in mice 
treated with antibiotics. 
Finally, we will evaluate whether also in the human intestine there is a GVU as in the 
mouse gut and if it will be the case we will use an organ culture method developed in our 
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